[1]		P04406	G3P_HUMAN	GAPDH	13	51.6	9.44	7.2e-17	756.0618	3	1.2	LTGMAFRVPTANVSVVDLTCR	LTGM(Oxidation)AFRVPTANVSVVDLTCR	Oxidation@231	21	V20130429-13_FTMSms2hcd	52.434	228	248	49.5	7.2e-17	1.1e-19	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	13	51.6	9.44	7.2e-17	845.4087	3	-0.15	IKWGDAGAEYVVESTGVFTTMEK	IKWGDAGAEYVVESTGVFTTM(Oxidation)EK	Oxidation@105	23	V20130429-13_FTMSms2hcd	53.749	85	107	48.0	8.9e-17	8.5e-20	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	13	51.6	9.44	7.2e-17	871.1246	3	1.7	VIHDNFGIVEGLMTTVHAITATQK	VIHDNFGIVEGLM(Oxidation)TTVHAITATQK	Oxidation@175	24	V20130429-13_FTMSms2hcd	61.663	163	186	54.0	4.9e-16	8.6e-19	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	13	51.6	9.44	7.2e-17	865.7970	3	6.4	VIHDNFGIVEGLMTTVHAITATQK	VIHDNFGIVEGLMTTVHAITATQK		24	V20130429-13_FTMSms2hcd	70.946	163	186	55.0	5.6e-16	1.5e-18	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	13	51.6	9.44	7.2e-17	882.4056	2	0.88	LISWYDNEFGYSNR	LISWYDNEFGYSNR		14	V20130429-13_FTMSms2hcd	49.426	310	323	54.3	2.4e-13	2.7e-16	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	13	51.6	9.44	7.2e-17	681.8235	2	0.39	VVDLMAHMASKE	VVDLM(Oxidation)AHM(Oxidation)ASKE	Oxidation@328;Oxidation@331	12	V20130429-13_FTMSms2hcd	16.104	324	335	39.8	3.7e-12	5.0e-15	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	13	51.6	9.44	7.2e-17	749.0386	3	0.93	VIISAPSADAPMFVMGVNHEK	VIISAPSADAPM(Oxidation)FVM(Oxidation)GVNHEK	Oxidation@130;Oxidation@133	21	V20130429-13_FTMSms2hcd	41.292	119	139	31.3	1.3e-9	1.4e-12	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	13	51.6	9.44	7.2e-17	737.3912	2	1.4	VPTANVSVVDLTCR	VPTANVSVVDLTCR		14	V20130429-13_FTMSms2hcd	43.294	235	248	52.6	1.4e-9	2.3e-12	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	13	51.6	9.44	7.2e-17	681.0404	3	-0.50	LVINGNPITIFQERDPSK	LVINGNPITIFQERDPSK		18	V20130429-13_FTMSms2hcd	52.195	67	84	34.3	1.1e-8	2.7e-11	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	13	51.6	9.44	7.2e-17	706.3994	2	0.83	GALQNIIPASTGAAK	GALQNIIPASTGAAK		15	V20130429-13_FTMSms2hcd	38.816	201	215	33.7	3.2e-8	8.7e-11	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	13	51.6	9.44	7.2e-17	362.7098	4	1.3	LEKPAKYDDIKK	LEKPAKYDDIKK		12	V20130429-13_FTMSms2hcd	14.008	249	260	25.2	2.1e-7	6.4e-10	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	13	51.6	9.44	7.2e-17	403.2194	2	0.014	VGVNGFGR	VGVNGFGR		8	V20130429-13_FTMSms2hcd	22.121	6	13	36.4	4.5e-6	8.4e-9	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	13	51.6	9.44	7.2e-17	635.8428	4	1.0	AENGKLVINGNPITIFQERDPSK	AENGKLVINGNPITIFQERDPSK		23	V20130429-13_FTMSms2hcd	48.491	62	84	16.7	4.2e-5	9.7e-8	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P07437	TBB5_HUMAN	TUBB	11	39.9	8.33	7.9e-15	681.3668	3	5.8	MAVTFIGNSTAIQELFKR	M(Oxidation)AVTFIGNSTAIQELFKR	Oxidation@363	18	V20130429-13_FTMSms2hcd	58.773	363	380	54.1	7.9e-15	1.6e-17	1	49671.3	HUMAN	Tubulin beta chain
[2]		P07437	TBB5_HUMAN	TUBB	11	39.9	8.33	7.9e-15	933.4533	3	0.71	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-13_FTMSms2hcd	61.249	78	103	47.1	5.5e-14	5.4e-17	5	49671.3	HUMAN	Tubulin beta chain
[2]		P07437	TBB5_HUMAN	TUBB	11	39.9	8.33	7.9e-15	546.2828	3	2.1	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-13_FTMSms2hcd	51.462	263	276	39.2	1.6e-12	2.0e-15	9	49671.3	HUMAN	Tubulin beta chain
[2]		P07437	TBB5_HUMAN	TUBB	11	39.9	8.33	7.9e-15	696.3648	3	1.5	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-13_FTMSms2hcd	58.021	104	122	37.9	2.5e-12	3.5e-15	5	49671.3	HUMAN	Tubulin beta chain
[2]		P07437	TBB5_HUMAN	TUBB	11	39.9	8.33	7.9e-15	830.4536	2	2.8	ALTVPELTQQVFDAK	ALTVPELTQQVFDAK		15	V20130429-13_FTMSms2hcd	56.760	283	297	38.7	1.2e-11	2.4e-14	1	49671.3	HUMAN	Tubulin beta chain
[2]		P07437	TBB5_HUMAN	TUBB	11	39.9	8.33	7.9e-15	848.9202	2	0.10	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-13_FTMSms2hcd	53.900	337	350	30.4	1.4e-11	1.6e-14	7	49671.3	HUMAN	Tubulin beta chain
[2]		P07437	TBB5_HUMAN	TUBB	11	39.9	8.33	7.9e-15	889.7745	3	-1.0	LTTPTYGDLNHLVSATMSGVTTCLR	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLR	Oxidation@233	25	V20130429-13_FTMSms2hcd	60.967	217	241	28.4	2.0e-11	2.2e-14	5	49671.3	HUMAN	Tubulin beta chain
[2]		P07437	TBB5_HUMAN	TUBB	11	39.9	8.33	7.9e-15	668.3549	2	3.6	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-13_FTMSms2hcd	36.221	163	174	37.0	1.0e-10	1.6e-13	4	49671.3	HUMAN	Tubulin beta chain
[2]		P07437	TBB5_HUMAN	TUBB	11	39.9	8.33	7.9e-15	520.3011	2	1.4	YLTVAAVFR	YLTVAAVFR		9	V20130429-13_FTMSms2hcd	48.082	310	318	42.4	8.8e-8	3.5e-10	3	49671.3	HUMAN	Tubulin beta chain
[2]		P07437	TBB5_HUMAN	TUBB	11	39.9	8.33	7.9e-15	539.2701	2	0.53	IREEYPDR	IREEYPDR		8	V20130429-13_FTMSms2hcd	11.979	155	162	38.1	3.5e-6	5.9e-9	8	49671.3	HUMAN	Tubulin beta chain
[2]		P07437	TBB5_HUMAN	TUBB	11	39.9	8.33	7.9e-15	589.3063	3	1.7	EIVHIQAGQCGNQIGAK	EIVHIQAGQCGNQIGAK		17	V20130429-13_FTMSms2hcd	29.836	3	19	18.5	9.0e-4	1.2e-6	6	49671.3	HUMAN	Tubulin beta chain
[2-1]	0	P68371	TBB4B_HUMAN	TUBB4B	9	32.4	7.88	5.5e-14	933.4533	3	0.71	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-13_FTMSms2hcd	61.249	78	103	47.1	5.5e-14	5.4e-17	5	49831.5	HUMAN	Tubulin beta-4B chain
[2-1]	0	P68371	TBB4B_HUMAN	TUBB4B	9	32.4	7.88	5.5e-14	546.2828	3	2.1	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-13_FTMSms2hcd	51.462	263	276	39.2	1.6e-12	2.0e-15	9	49831.5	HUMAN	Tubulin beta-4B chain
[2-1]	0	P68371	TBB4B_HUMAN	TUBB4B	9	32.4	7.88	5.5e-14	696.3648	3	1.5	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-13_FTMSms2hcd	58.021	104	122	37.9	2.5e-12	3.5e-15	5	49831.5	HUMAN	Tubulin beta-4B chain
[2-1]	0	P68371	TBB4B_HUMAN	TUBB4B	9	32.4	7.88	5.5e-14	848.9202	2	0.10	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-13_FTMSms2hcd	53.900	337	350	30.4	1.4e-11	1.6e-14	7	49831.5	HUMAN	Tubulin beta-4B chain
[2-1]	0	P68371	TBB4B_HUMAN	TUBB4B	9	32.4	7.88	5.5e-14	889.7745	3	-1.0	LTTPTYGDLNHLVSATMSGVTTCLR	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLR	Oxidation@233	25	V20130429-13_FTMSms2hcd	60.967	217	241	28.4	2.0e-11	2.2e-14	5	49831.5	HUMAN	Tubulin beta-4B chain
[2-1]	0	P68371	TBB4B_HUMAN	TUBB4B	9	32.4	7.88	5.5e-14	668.3549	2	3.6	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-13_FTMSms2hcd	36.221	163	174	37.0	1.0e-10	1.6e-13	4	49831.5	HUMAN	Tubulin beta-4B chain
[2-1]	0	P68371	TBB4B_HUMAN	TUBB4B	9	32.4	7.88	5.5e-14	520.3011	2	1.4	YLTVAAVFR	YLTVAAVFR		9	V20130429-13_FTMSms2hcd	48.082	310	318	42.4	8.8e-8	3.5e-10	3	49831.5	HUMAN	Tubulin beta-4B chain
[2-1]	0	P68371	TBB4B_HUMAN	TUBB4B	9	32.4	7.88	5.5e-14	539.2701	2	0.53	IREEYPDR	IREEYPDR		8	V20130429-13_FTMSms2hcd	11.979	155	162	38.1	3.5e-6	5.9e-9	8	49831.5	HUMAN	Tubulin beta-4B chain
[2-1]	0	P68371	TBB4B_HUMAN	TUBB4B	9	32.4	7.88	5.5e-14	589.3063	3	1.7	EIVHLQAGQCGNQIGAK	EIVHLQAGQCGNQIGAK		17	V20130429-13_FTMSms2hcd	29.836	3	19	18.5	9.0e-4	1.2e-6	6	49831.5	HUMAN	Tubulin beta-4B chain
[2-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	7	27.6	7.88	5.5e-14	933.4533	3	0.71	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-13_FTMSms2hcd	61.249	78	103	47.1	5.5e-14	5.4e-17	5	49907.4	HUMAN	Tubulin beta-2A chain
[2-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	7	27.6	7.88	5.5e-14	546.2828	3	2.1	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-13_FTMSms2hcd	51.462	263	276	39.2	1.6e-12	2.0e-15	9	49907.4	HUMAN	Tubulin beta-2A chain
[2-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	7	27.6	7.88	5.5e-14	696.3648	3	1.5	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-13_FTMSms2hcd	58.021	104	122	37.9	2.5e-12	3.5e-15	5	49907.4	HUMAN	Tubulin beta-2A chain
[2-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	7	27.6	7.88	5.5e-14	848.9202	2	0.10	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-13_FTMSms2hcd	53.900	337	350	30.4	1.4e-11	1.6e-14	7	49907.4	HUMAN	Tubulin beta-2A chain
[2-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	7	27.6	7.88	5.5e-14	889.7745	3	-1.0	LTTPTYGDLNHLVSATMSGVTTCLR	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLR	Oxidation@233	25	V20130429-13_FTMSms2hcd	60.967	217	241	28.4	2.0e-11	2.2e-14	5	49907.4	HUMAN	Tubulin beta-2A chain
[2-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	7	27.6	7.88	5.5e-14	539.2701	2	0.53	IREEYPDR	IREEYPDR		8	V20130429-13_FTMSms2hcd	11.979	155	162	38.1	3.5e-6	5.9e-9	8	49907.4	HUMAN	Tubulin beta-2A chain
[2-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	7	27.6	7.88	5.5e-14	589.3063	3	1.7	EIVHIQAGQCGNQIGAK	EIVHIQAGQCGNQIGAK		17	V20130429-13_FTMSms2hcd	29.836	3	19	18.5	9.0e-4	1.2e-6	6	49907.4	HUMAN	Tubulin beta-2A chain
[2-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	7	27.6	7.88	5.5e-14	933.4533	3	0.71	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-13_FTMSms2hcd	61.249	78	103	47.1	5.5e-14	5.4e-17	5	49953.5	HUMAN	Tubulin beta-2B chain
[2-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	7	27.6	7.88	5.5e-14	546.2828	3	2.1	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-13_FTMSms2hcd	51.462	263	276	39.2	1.6e-12	2.0e-15	9	49953.5	HUMAN	Tubulin beta-2B chain
[2-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	7	27.6	7.88	5.5e-14	696.3648	3	1.5	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-13_FTMSms2hcd	58.021	104	122	37.9	2.5e-12	3.5e-15	5	49953.5	HUMAN	Tubulin beta-2B chain
[2-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	7	27.6	7.88	5.5e-14	848.9202	2	0.10	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-13_FTMSms2hcd	53.900	337	350	30.4	1.4e-11	1.6e-14	7	49953.5	HUMAN	Tubulin beta-2B chain
[2-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	7	27.6	7.88	5.5e-14	889.7745	3	-1.0	LTTPTYGDLNHLVSATMSGVTTCLR	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLR	Oxidation@233	25	V20130429-13_FTMSms2hcd	60.967	217	241	28.4	2.0e-11	2.2e-14	5	49953.5	HUMAN	Tubulin beta-2B chain
[2-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	7	27.6	7.88	5.5e-14	539.2701	2	0.53	IREEYPDR	IREEYPDR		8	V20130429-13_FTMSms2hcd	11.979	155	162	38.1	3.5e-6	5.9e-9	8	49953.5	HUMAN	Tubulin beta-2B chain
[2-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	7	27.6	7.88	5.5e-14	589.3063	3	1.7	EIVHIQAGQCGNQIGAK	EIVHIQAGQCGNQIGAK		17	V20130429-13_FTMSms2hcd	29.836	3	19	18.5	9.0e-4	1.2e-6	6	49953.5	HUMAN	Tubulin beta-2B chain
[2-4]	0	P04350	TBB4A_HUMAN	TUBB4A	7	26.4	7.88	5.5e-14	933.4533	3	0.71	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-13_FTMSms2hcd	61.249	78	103	47.1	5.5e-14	5.4e-17	5	49586.2	HUMAN	Tubulin beta-4A chain
[2-4]	0	P04350	TBB4A_HUMAN	TUBB4A	7	26.4	7.88	5.5e-14	546.2828	3	2.1	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-13_FTMSms2hcd	51.462	263	276	39.2	1.6e-12	2.0e-15	9	49586.2	HUMAN	Tubulin beta-4A chain
[2-4]	0	P04350	TBB4A_HUMAN	TUBB4A	7	26.4	7.88	5.5e-14	848.9202	2	0.10	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-13_FTMSms2hcd	53.900	337	350	30.4	1.4e-11	1.6e-14	7	49586.2	HUMAN	Tubulin beta-4A chain
[2-4]	0	P04350	TBB4A_HUMAN	TUBB4A	7	26.4	7.88	5.5e-14	889.7745	3	-1.0	LTTPTYGDLNHLVSATMSGVTTCLR	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLR	Oxidation@233	25	V20130429-13_FTMSms2hcd	60.967	217	241	28.4	2.0e-11	2.2e-14	5	49586.2	HUMAN	Tubulin beta-4A chain
[2-4]	0	P04350	TBB4A_HUMAN	TUBB4A	7	26.4	7.88	5.5e-14	668.3549	2	3.6	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-13_FTMSms2hcd	36.221	163	174	37.0	1.0e-10	1.6e-13	4	49586.2	HUMAN	Tubulin beta-4A chain
[2-4]	0	P04350	TBB4A_HUMAN	TUBB4A	7	26.4	7.88	5.5e-14	520.3011	2	1.4	YLTVAAVFR	YLTVAAVFR		9	V20130429-13_FTMSms2hcd	48.082	310	318	42.4	8.8e-8	3.5e-10	3	49586.2	HUMAN	Tubulin beta-4A chain
[2-4]	0	P04350	TBB4A_HUMAN	TUBB4A	7	26.4	7.88	5.5e-14	589.3063	3	1.7	EIVHLQAGQCGNQIGAK	EIVHLQAGQCGNQIGAK		17	V20130429-13_FTMSms2hcd	29.836	3	19	18.5	9.0e-4	1.2e-6	6	49586.2	HUMAN	Tubulin beta-4A chain
[2-5]	0	Q13509	TBB3_HUMAN	TUBB3	4	13.8	6.78	2.5e-12	696.3648	3	1.5	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-13_FTMSms2hcd	58.021	104	122	37.9	2.5e-12	3.5e-15	5	50433.2	HUMAN	Tubulin beta-3 chain
[2-5]	0	Q13509	TBB3_HUMAN	TUBB3	4	13.8	6.78	2.5e-12	848.9202	2	0.10	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-13_FTMSms2hcd	53.900	337	350	30.4	1.4e-11	1.6e-14	7	50433.2	HUMAN	Tubulin beta-3 chain
[2-5]	0	Q13509	TBB3_HUMAN	TUBB3	4	13.8	6.78	2.5e-12	668.3549	2	3.6	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-13_FTMSms2hcd	36.221	163	174	37.0	1.0e-10	1.6e-13	4	50433.2	HUMAN	Tubulin beta-3 chain
[2-5]	0	Q13509	TBB3_HUMAN	TUBB3	4	13.8	6.78	2.5e-12	589.3063	3	1.7	EIVHIQAGQCGNQIGAK	EIVHIQAGQCGNQIGAK		17	V20130429-13_FTMSms2hcd	29.836	3	19	18.5	9.0e-4	1.2e-6	6	50433.2	HUMAN	Tubulin beta-3 chain
[2-6]	0	Q9BUF5	TBB6_HUMAN	TUBB6	2	6.3	7.01	1.6e-12	546.2828	3	2.1	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-13_FTMSms2hcd	51.462	263	276	39.2	1.6e-12	2.0e-15	9	49857.6	HUMAN	Tubulin beta-6 chain
[2-6]	0	Q9BUF5	TBB6_HUMAN	TUBB6	2	6.3	7.01	1.6e-12	848.9202	2	0.10	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-13_FTMSms2hcd	53.900	337	350	30.4	1.4e-11	1.6e-14	7	49857.6	HUMAN	Tubulin beta-6 chain
[2-7]	0	Q3ZCM7	TBB8_HUMAN	TUBB8	2	5.0	7.01	1.6e-12	546.2828	3	2.1	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-13_FTMSms2hcd	51.462	263	276	39.2	1.6e-12	2.0e-15	9	49776.5	HUMAN	Tubulin beta-8 chain
[2-7]	0	Q3ZCM7	TBB8_HUMAN	TUBB8	2	5.0	7.01	1.6e-12	539.2701	2	0.53	IREEYPDR	IREEYPDR		8	V20130429-13_FTMSms2hcd	11.979	155	162	38.1	3.5e-6	5.9e-9	8	49776.5	HUMAN	Tubulin beta-8 chain
[2-8]	0	A6NKZ8	YI016_HUMAN		2	5.9	7.01	1.6e-12	546.2828	3	2.1	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@195	14	V20130429-13_FTMSms2hcd	51.462	191	204	39.2	1.6e-12	2.0e-15	9	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[2-8]	0	A6NKZ8	YI016_HUMAN		2	5.9	7.01	1.6e-12	539.2701	2	0.53	IREEYPDR	IREEYPDR		8	V20130429-13_FTMSms2hcd	11.979	83	90	38.1	3.5e-6	5.9e-9	8	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[2-9]	0	A6NNZ2	TBB8B_HUMAN		2	5.0	7.01	1.6e-12	546.2828	3	2.1	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-13_FTMSms2hcd	51.462	263	276	39.2	1.6e-12	2.0e-15	9	49573.1	HUMAN	Tubulin beta-8 chain B
[2-9]	0	A6NNZ2	TBB8B_HUMAN		2	5.0	7.01	1.6e-12	539.2701	2	0.53	IREEYPDR	IREEYPDR		8	V20130429-13_FTMSms2hcd	11.979	155	162	38.1	3.5e-6	5.9e-9	8	49573.1	HUMAN	Tubulin beta-8 chain B
[2-10]	1	Q9H4B7	TBB1_HUMAN	TUBB1	2	8.4	3.47	3.5e-6	539.2701	2	0.53	IREEYPDR	IREEYPDR		8	V20130429-13_FTMSms2hcd	11.979	155	162	38.1	3.5e-6	5.9e-9	8	50327.4	HUMAN	Tubulin beta-1 chain
[2-10]	1	Q9H4B7	TBB1_HUMAN	TUBB1	2	8.4	3.47	3.5e-6	895.9100	4	-18	LAVNMVPFPRLHFFMPGFAPLTAQGSQQYR	LAVNMVPFPRLHFFMPGFAPLT(Phospho)AQGS(Phospho)QQYR	Phospho@278=7;Phospho@274|281	30	V20130429-13_FTMSms2hcd	44.599	253	282	13.3	0.051	5.4e-5	1	50327.4	HUMAN	Tubulin beta-1 chain
[3]		P60709	ACTB_HUMAN	ACTB	9	26.7	12.29	3.7e-22	890.8915	2	1.6	MDDDIAALVVDNGSGMCK	M(Met-loss+Acetyl)DDDIAALVVDNGSGM(Oxidation)CK	Met-loss+Acetyl@1;Oxidation@16	18	V20130429-13_FTMSms2hcd	52.182	1	18	58.5	3.7e-22	4.8e-25	1	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	9	26.7	12.29	3.7e-22	790.9046	2	-0.20	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@313;Oxidation@325	14	V20130429-13_FTMSms2hcd	23.069	313	326	39.7	3.0e-15	3.8e-18	6	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	9	26.7	12.29	3.7e-22	895.9508	2	1.3	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-13_FTMSms2hcd	47.775	239	254	51.9	1.8e-12	2.0e-15	10	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	9	26.7	12.29	3.7e-22	977.5364	2	0.57	VAPEEHPVLLTEAPLNPK	VAPEEHPVLLTEAPLNPK		18	V20130429-13_FTMSms2hcd	40.909	96	113	46.8	2.5e-12	6.6e-15	2	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	9	26.7	12.29	3.7e-22	589.3111	2	1.4	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@325	11	V20130429-13_FTMSms2hcd	24.939	316	326	41.5	5.7e-12	8.8e-15	6	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	9	26.7	12.29	3.7e-22	677.8151	2	-0.31	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-13_FTMSms2hcd	11.692	51	62	40.8	2.0e-11	2.6e-14	6	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	9	26.7	12.29	3.7e-22	400.2405	3	1.2	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-13_FTMSms2hcd	35.312	29	39	42.6	1.8e-10	6.3e-13	9	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	9	26.7	12.29	3.7e-22	505.9212	3	-0.073	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-13_FTMSms2hcd	31.011	85	95	26.1	9.8e-10	1.3e-12	9	41737.1	HUMAN	Actin, cytoplasmic 1
[3]		P60709	ACTB_HUMAN	ACTB	9	26.7	12.29	3.7e-22	599.7651	2	0.57	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-13_FTMSms2hcd	13.121	51	61	21.2	7.6e-6	1.5e-8	6	41737.1	HUMAN	Actin, cytoplasmic 1
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	9	26.7	11.95	1.6e-21	918.9224	2	1.2	MEEEIAALVIDNGSGMCK	M(Met-loss+Acetyl)EEEIAALVIDNGSGM(Oxidation)CK	Met-loss+Acetyl@1;Oxidation@16	18	V20130429-13_FTMSms2hcd	60.535	1	18	59.1	1.6e-21	1.8e-24	1	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	9	26.7	11.95	1.6e-21	790.9046	2	-0.20	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@313;Oxidation@325	14	V20130429-13_FTMSms2hcd	23.069	313	326	39.7	3.0e-15	3.8e-18	6	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	9	26.7	11.95	1.6e-21	895.9508	2	1.3	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-13_FTMSms2hcd	47.775	239	254	51.9	1.8e-12	2.0e-15	10	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	9	26.7	11.95	1.6e-21	977.5364	2	0.57	VAPEEHPVLLTEAPLNPK	VAPEEHPVLLTEAPLNPK		18	V20130429-13_FTMSms2hcd	40.909	96	113	46.8	2.5e-12	6.6e-15	2	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	9	26.7	11.95	1.6e-21	589.3111	2	1.4	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@325	11	V20130429-13_FTMSms2hcd	24.939	316	326	41.5	5.7e-12	8.8e-15	6	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	9	26.7	11.95	1.6e-21	677.8151	2	-0.31	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-13_FTMSms2hcd	11.692	51	62	40.8	2.0e-11	2.6e-14	6	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	9	26.7	11.95	1.6e-21	400.2405	3	1.2	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-13_FTMSms2hcd	35.312	29	39	42.6	1.8e-10	6.3e-13	9	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	9	26.7	11.95	1.6e-21	505.9212	3	-0.073	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-13_FTMSms2hcd	31.011	85	95	26.1	9.8e-10	1.3e-12	9	41793.2	HUMAN	Actin, cytoplasmic 2
[3-1]	1	P63261	ACTG_HUMAN	ACTG1	9	26.7	11.95	1.6e-21	599.7651	2	0.57	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-13_FTMSms2hcd	13.121	51	61	21.2	7.6e-6	1.5e-8	6	41793.2	HUMAN	Actin, cytoplasmic 2
[3-2]	1	P68032	ACTC_HUMAN	ACTC1	8	24.4	8.57	3.0e-15	790.9046	2	-0.20	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-13_FTMSms2hcd	23.069	315	328	39.7	3.0e-15	3.8e-18	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	1	P68032	ACTC_HUMAN	ACTC1	8	24.4	8.57	3.0e-15	895.9508	2	1.3	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-13_FTMSms2hcd	47.775	241	256	51.9	1.8e-12	2.0e-15	10	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	1	P68032	ACTC_HUMAN	ACTC1	8	24.4	8.57	3.0e-15	589.3111	2	1.4	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-13_FTMSms2hcd	24.939	318	328	41.5	5.7e-12	8.8e-15	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	1	P68032	ACTC_HUMAN	ACTC1	8	24.4	8.57	3.0e-15	677.8151	2	-0.31	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-13_FTMSms2hcd	11.692	53	64	40.8	2.0e-11	2.6e-14	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	1	P68032	ACTC_HUMAN	ACTC1	8	24.4	8.57	3.0e-15	400.2405	3	1.2	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-13_FTMSms2hcd	35.312	31	41	42.6	1.8e-10	6.3e-13	9	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	1	P68032	ACTC_HUMAN	ACTC1	8	24.4	8.57	3.0e-15	505.9212	3	-0.073	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-13_FTMSms2hcd	31.011	87	97	26.1	9.8e-10	1.3e-12	9	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	1	P68032	ACTC_HUMAN	ACTC1	8	24.4	8.57	3.0e-15	1049.8005	3	-19	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=42	28	V20130429-13_FTMSms2hcd	59.133	259	286	19.9	1.5e-6	1.5e-9	4	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-2]	1	P68032	ACTC_HUMAN	ACTC1	8	24.4	8.57	3.0e-15	599.7651	2	0.57	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-13_FTMSms2hcd	13.121	53	63	21.2	7.6e-6	1.5e-8	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[3-3]	1	P68133	ACTS_HUMAN	ACTA1	8	24.4	8.57	3.0e-15	790.9046	2	-0.20	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-13_FTMSms2hcd	23.069	315	328	39.7	3.0e-15	3.8e-18	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	1	P68133	ACTS_HUMAN	ACTA1	8	24.4	8.57	3.0e-15	895.9508	2	1.3	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-13_FTMSms2hcd	47.775	241	256	51.9	1.8e-12	2.0e-15	10	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	1	P68133	ACTS_HUMAN	ACTA1	8	24.4	8.57	3.0e-15	589.3111	2	1.4	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-13_FTMSms2hcd	24.939	318	328	41.5	5.7e-12	8.8e-15	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	1	P68133	ACTS_HUMAN	ACTA1	8	24.4	8.57	3.0e-15	677.8151	2	-0.31	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-13_FTMSms2hcd	11.692	53	64	40.8	2.0e-11	2.6e-14	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	1	P68133	ACTS_HUMAN	ACTA1	8	24.4	8.57	3.0e-15	400.2405	3	1.2	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-13_FTMSms2hcd	35.312	31	41	42.6	1.8e-10	6.3e-13	9	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	1	P68133	ACTS_HUMAN	ACTA1	8	24.4	8.57	3.0e-15	505.9212	3	-0.073	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-13_FTMSms2hcd	31.011	87	97	26.1	9.8e-10	1.3e-12	9	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	1	P68133	ACTS_HUMAN	ACTA1	8	24.4	8.57	3.0e-15	1049.8005	3	-19	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=42	28	V20130429-13_FTMSms2hcd	59.133	259	286	19.9	1.5e-6	1.5e-9	4	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-3]	1	P68133	ACTS_HUMAN	ACTA1	8	24.4	8.57	3.0e-15	599.7651	2	0.57	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-13_FTMSms2hcd	13.121	53	63	21.2	7.6e-6	1.5e-8	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[3-4]	1	P62736	ACTA_HUMAN	ACTA2	7	21.5	8.57	3.0e-15	790.9046	2	-0.20	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-13_FTMSms2hcd	23.069	315	328	39.7	3.0e-15	3.8e-18	6	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	1	P62736	ACTA_HUMAN	ACTA2	7	21.5	8.57	3.0e-15	895.9508	2	1.3	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-13_FTMSms2hcd	47.775	241	256	51.9	1.8e-12	2.0e-15	10	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	1	P62736	ACTA_HUMAN	ACTA2	7	21.5	8.57	3.0e-15	589.3111	2	1.4	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-13_FTMSms2hcd	24.939	318	328	41.5	5.7e-12	8.8e-15	6	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	1	P62736	ACTA_HUMAN	ACTA2	7	21.5	8.57	3.0e-15	677.8151	2	-0.31	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-13_FTMSms2hcd	11.692	53	64	40.8	2.0e-11	2.6e-14	6	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	1	P62736	ACTA_HUMAN	ACTA2	7	21.5	8.57	3.0e-15	400.2405	3	1.2	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-13_FTMSms2hcd	35.312	31	41	42.6	1.8e-10	6.3e-13	9	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	1	P62736	ACTA_HUMAN	ACTA2	7	21.5	8.57	3.0e-15	1049.8005	3	-19	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=42	28	V20130429-13_FTMSms2hcd	59.133	259	286	19.9	1.5e-6	1.5e-9	4	42009.4	HUMAN	Actin, aortic smooth muscle
[3-4]	1	P62736	ACTA_HUMAN	ACTA2	7	21.5	8.57	3.0e-15	599.7651	2	0.57	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-13_FTMSms2hcd	13.121	53	63	21.2	7.6e-6	1.5e-8	6	42009.4	HUMAN	Actin, aortic smooth muscle
[3-5]	1	P63267	ACTH_HUMAN	ACTG2	7	21.5	8.57	3.0e-15	790.9046	2	-0.20	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@314;Oxidation@326	14	V20130429-13_FTMSms2hcd	23.069	314	327	39.7	3.0e-15	3.8e-18	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	1	P63267	ACTH_HUMAN	ACTG2	7	21.5	8.57	3.0e-15	895.9508	2	1.3	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-13_FTMSms2hcd	47.775	240	255	51.9	1.8e-12	2.0e-15	10	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	1	P63267	ACTH_HUMAN	ACTG2	7	21.5	8.57	3.0e-15	589.3111	2	1.4	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@326	11	V20130429-13_FTMSms2hcd	24.939	317	327	41.5	5.7e-12	8.8e-15	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	1	P63267	ACTH_HUMAN	ACTG2	7	21.5	8.57	3.0e-15	677.8151	2	-0.31	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-13_FTMSms2hcd	11.692	52	63	40.8	2.0e-11	2.6e-14	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	1	P63267	ACTH_HUMAN	ACTG2	7	21.5	8.57	3.0e-15	400.2405	3	1.2	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-13_FTMSms2hcd	35.312	30	40	42.6	1.8e-10	6.3e-13	9	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	1	P63267	ACTH_HUMAN	ACTG2	7	21.5	8.57	3.0e-15	1049.8005	3	-19	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@270=42	28	V20130429-13_FTMSms2hcd	59.133	258	285	19.9	1.5e-6	1.5e-9	4	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-5]	1	P63267	ACTH_HUMAN	ACTG2	7	21.5	8.57	3.0e-15	599.7651	2	0.57	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-13_FTMSms2hcd	13.121	52	62	21.2	7.6e-6	1.5e-8	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[3-6]	0	Q6S8J3	POTEE_HUMAN	POTEE	3	3.5	7.07	1.8e-12	895.9508	2	1.3	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-13_FTMSms2hcd	47.775	939	954	51.9	1.8e-12	2.0e-15	10	121364.6	HUMAN	POTE ankyrin domain family member E
[3-6]	0	Q6S8J3	POTEE_HUMAN	POTEE	3	3.5	7.07	1.8e-12	400.2405	3	1.2	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-13_FTMSms2hcd	35.312	729	739	42.6	1.8e-10	6.3e-13	9	121364.6	HUMAN	POTE ankyrin domain family member E
[3-6]	0	Q6S8J3	POTEE_HUMAN	POTEE	3	3.5	7.07	1.8e-12	505.9212	3	-0.073	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-13_FTMSms2hcd	31.011	785	795	26.1	9.8e-10	1.3e-12	9	121364.6	HUMAN	POTE ankyrin domain family member E
[3-7]	0	A5A3E0	POTEF_HUMAN	POTEF	3	3.5	7.07	1.8e-12	895.9508	2	1.3	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-13_FTMSms2hcd	47.775	939	954	51.9	1.8e-12	2.0e-15	10	121445.7	HUMAN	POTE ankyrin domain family member F
[3-7]	0	A5A3E0	POTEF_HUMAN	POTEF	3	3.5	7.07	1.8e-12	400.2405	3	1.2	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-13_FTMSms2hcd	35.312	729	739	42.6	1.8e-10	6.3e-13	9	121445.7	HUMAN	POTE ankyrin domain family member F
[3-7]	0	A5A3E0	POTEF_HUMAN	POTEF	3	3.5	7.07	1.8e-12	505.9212	3	-0.073	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-13_FTMSms2hcd	31.011	785	795	26.1	9.8e-10	1.3e-12	9	121445.7	HUMAN	POTE ankyrin domain family member F
[3-8]	0	Q9BYX7	ACTBM_HUMAN	POTEKP	2	7.2	7.07	1.8e-12	895.9508	2	1.3	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-13_FTMSms2hcd	47.775	239	254	51.9	1.8e-12	2.0e-15	10	42016.6	HUMAN	Putative beta-actin-like protein 3
[3-8]	0	Q9BYX7	ACTBM_HUMAN	POTEKP	2	7.2	7.07	1.8e-12	505.9212	3	-0.073	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-13_FTMSms2hcd	31.011	85	95	26.1	9.8e-10	1.3e-12	9	42016.6	HUMAN	Putative beta-actin-like protein 3
[3-9]	0	P0CG38	POTEI_HUMAN	POTEI	2	2.0	5.99	1.8e-10	400.2405	3	1.2	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-13_FTMSms2hcd	35.312	729	739	42.6	1.8e-10	6.3e-13	9	121283.5	HUMAN	POTE ankyrin domain family member I
[3-9]	0	P0CG38	POTEI_HUMAN	POTEI	2	2.0	5.99	1.8e-10	505.9212	3	-0.073	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-13_FTMSms2hcd	31.011	785	795	26.1	9.8e-10	1.3e-12	9	121283.5	HUMAN	POTE ankyrin domain family member I
[3-10]	1	Q562R1	ACTBL_HUMAN	ACTBL2	2	11.7	7.07	1.8e-12	895.9508	2	1.3	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-13_FTMSms2hcd	47.775	240	255	51.9	1.8e-12	2.0e-15	10	42003.6	HUMAN	Beta-actin-like protein 2
[3-10]	1	Q562R1	ACTBL_HUMAN	ACTBL2	2	11.7	7.07	1.8e-12	1010.8200	3	-6.8	CDVDIRKDLYANTVLSGGSTMYPGIADR	CDVDIRKDLYANTVLSGGSTMYPGIADR		28	V20130429-13_FTMSms2hcd	54.247	286	313	16.1	0.0073	7.6e-6	1	42003.6	HUMAN	Beta-actin-like protein 2
[3-11]	0	P0CG39	POTEJ_HUMAN	POTEJ	1	1.1	4.19	9.8e-10	505.9212	3	-0.073	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-13_FTMSms2hcd	31.011	748	758	26.1	9.8e-10	1.3e-12	9	117391.0	HUMAN	POTE ankyrin domain family member J
[4]		P68104	EF1A1_HUMAN	EEF1A1	9	26.0	10.09	4.5e-18	897.4935	3	1.3	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-13_FTMSms2hcd	37.827	6	30	54.8	4.5e-18	1.9e-20	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[4]		P68104	EF1A1_HUMAN	EEF1A1	9	26.0	10.09	4.5e-18	794.9413	2	-3.3	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-13_FTMSms2hcd	77.801	6	20	46.2	2.3e-17	4.6e-20	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[4]		P68104	EF1A1_HUMAN	EEF1A1	9	26.0	10.09	4.5e-18	542.9392	3	-0.80	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-13_FTMSms2hcd	21.469	38	51	42.6	7.4e-13	8.7e-16	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[4]		P68104	EF1A1_HUMAN	EEF1A1	9	26.0	10.09	4.5e-18	1013.0499	4	0.94	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		37	V20130429-13_FTMSms2hcd	70.056	219	255	47.3	2.4e-12	1.3e-14	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[4]		P68104	EF1A1_HUMAN	EEF1A1	9	26.0	10.09	4.5e-18	981.0300	4	4.9	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		36	V20130429-13_FTMSms2hcd	74.076	220	255	39.8	4.0e-12	1.9e-14	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[4]		P68104	EF1A1_HUMAN	EEF1A1	9	26.0	10.09	4.5e-18	844.4661	3	1.9	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGM(Oxidation)VVTFAPVNVTTEVK	Oxidation@276	24	V20130429-13_FTMSms2hcd	51.114	267	290	34.2	3.6e-10	1.4e-12	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[4]		P68104	EF1A1_HUMAN	EEF1A1	9	26.0	10.09	4.5e-18	560.8034	2	-0.16	STTTGHLIYK	STTTGHLIYK		10	V20130429-13_FTMSms2hcd	17.778	21	30	36.6	8.8e-9	1.5e-11	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[4]		P68104	EF1A1_HUMAN	EEF1A1	9	26.0	10.09	4.5e-18	513.3093	2	1.1	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-13_FTMSms2hcd	31.201	256	266	44.6	3.8e-7	2.8e-9	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[4]		P68104	EF1A1_HUMAN	EEF1A1	9	26.0	10.09	4.5e-18	457.7822	2	-11	QTVAVGVIK	QTVAVGVIK		9	V20130429-13_FTMSms2hcd	26.435	431	439	28.1	2.8e-5	8.3e-8	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[4-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	9	26.0	10.09	4.5e-18	897.4935	3	1.3	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-13_FTMSms2hcd	37.827	6	30	54.8	4.5e-18	1.9e-20	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[4-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	9	26.0	10.09	4.5e-18	794.9413	2	-3.3	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-13_FTMSms2hcd	77.801	6	20	46.2	2.3e-17	4.6e-20	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[4-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	9	26.0	10.09	4.5e-18	542.9392	3	-0.80	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-13_FTMSms2hcd	21.469	38	51	42.6	7.4e-13	8.7e-16	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[4-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	9	26.0	10.09	4.5e-18	1013.0499	4	0.94	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		37	V20130429-13_FTMSms2hcd	70.056	219	255	47.3	2.4e-12	1.3e-14	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[4-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	9	26.0	10.09	4.5e-18	981.0300	4	4.9	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		36	V20130429-13_FTMSms2hcd	74.076	220	255	39.8	4.0e-12	1.9e-14	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[4-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	9	26.0	10.09	4.5e-18	844.4661	3	1.9	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGM(Oxidation)VVTFAPVNVTTEVK	Oxidation@276	24	V20130429-13_FTMSms2hcd	51.114	267	290	34.2	3.6e-10	1.4e-12	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[4-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	9	26.0	10.09	4.5e-18	560.8034	2	-0.16	STTTGHLIYK	STTTGHLIYK		10	V20130429-13_FTMSms2hcd	17.778	21	30	36.6	8.8e-9	1.5e-11	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[4-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	9	26.0	10.09	4.5e-18	513.3093	2	1.1	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-13_FTMSms2hcd	31.201	256	266	44.6	3.8e-7	2.8e-9	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[4-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	9	26.0	10.09	4.5e-18	457.7822	2	-11	QTVAVGVIK	QTVAVGVIK		9	V20130429-13_FTMSms2hcd	26.435	431	439	28.1	2.8e-5	8.3e-8	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[4-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	7	20.7	10.09	4.5e-18	897.4935	3	1.3	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-13_FTMSms2hcd	37.827	6	30	54.8	4.5e-18	1.9e-20	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[4-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	7	20.7	10.09	4.5e-18	794.9413	2	-3.3	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-13_FTMSms2hcd	77.801	6	20	46.2	2.3e-17	4.6e-20	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[4-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	7	20.7	10.09	4.5e-18	542.9392	3	-0.80	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-13_FTMSms2hcd	21.469	38	51	42.6	7.4e-13	8.7e-16	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[4-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	7	20.7	10.09	4.5e-18	560.8034	2	-0.16	STTTGHLIYK	STTTGHLIYK		10	V20130429-13_FTMSms2hcd	17.778	21	30	36.6	8.8e-9	1.5e-11	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[4-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	7	20.7	10.09	4.5e-18	513.3093	2	1.1	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-13_FTMSms2hcd	31.201	256	266	44.6	3.8e-7	2.8e-9	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[4-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	7	20.7	10.09	4.5e-18	457.7822	2	-11	QTVAVGVIK	QTVAVGVIK		9	V20130429-13_FTMSms2hcd	26.435	431	439	28.1	2.8e-5	8.3e-8	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[4-2]	1	Q05639	EF1A2_HUMAN	EEF1A2	7	20.7	10.09	4.5e-18	1032.0410	4	-14	KEGNASGVSLLEALDTILPPTRPTDKPLRLPLQDVYK	KEGNASGVS(Phospho)LLEALDTILPPTRPTDKPLRLPLQDVYK	Phospho@224|227|234	37	V20130429-13_FTMSms2hcd	72.722	219	255	18.7	8.4e-5	2.7e-7	1	50470.6	HUMAN	Elongation factor 1-alpha 2
[5]		P14618	KPYM_HUMAN	PKM2	8	29.0	11.32	2.3e-20	1006.5358	3	-0.46	TATESFASDPILYRPVAVALDTKGPEIR	TATESFASDPILYRPVAVALDTKGPEIR		28	V20130429-13_FTMSms2hcd	56.424	93	120	69.2	2.3e-20	5.7e-23	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	8	29.0	11.32	2.3e-20	1088.0647	2	1.9	LAPITSDPTEATAVGAVEASFK	LAPITSDPTEATAVGAVEASFK		22	V20130429-13_FTMSms2hcd	55.207	401	422	54.1	5.4e-14	7.2e-17	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	8	29.0	11.32	2.3e-20	803.0906	3	0.90	KGDVVIVLTGWRPGSGFTNTMR	KGDVVIVLTGWRPGSGFTNTM(Oxidation)R	Oxidation@525	22	V20130429-13_FTMSms2hcd	49.989	505	526	43.1	1.8e-13	3.2e-16	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	8	29.0	11.32	2.3e-20	834.0905	3	1.1	GIFPVLCKDPVQEAWAEDVDLR	GIFPVLCKDPVQEAWAEDVDLR		22	V20130429-13_FTMSms2hcd	64.417	468	489	33.1	4.1e-13	5.2e-16	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	8	29.0	11.32	2.3e-20	706.9317	5	1.3	MSKPHSEAGTAFIQTQQLHAAMADTFLEHMCR	M(Met-loss+Acetyl)SKPHSEAGTAFIQTQQLHAAM(Oxidation)ADTFLEHM(Oxidation)CR	Met-loss+Acetyl@1;Oxidation@22;Oxidation@30	32	V20130429-13_FTMSms2hcd	45.092	1	32	44.0	1.4e-12	1.4e-15	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	8	29.0	11.32	2.3e-20	663.3363	3	-0.13	FGVEQDVDMVFASFIRK	FGVEQDVDMVFASFIRK		17	V20130429-13_FTMSms2hcd	71.300	231	247	19.2	1.4e-8	1.6e-11	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	8	29.0	11.32	2.3e-20	625.9689	3	-1.3	FGVEQDVDMVFASFIR	FGVEQDVDM(Oxidation)VFASFIR	Oxidation@239	16	V20130429-13_FTMSms2hcd	73.929	231	246	13.2	2.2e-4	2.3e-7	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[5]		P14618	KPYM_HUMAN	PKM2	8	29.0	11.32	2.3e-20	599.3293	2	3.3	LDIDSPPITAR	LDIDSPPITAR		11	V20130429-13_FTMSms2hcd	35.988	33	43	20.0	6.5e-4	1.5e-6	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[6]		P11142	HSP7C_HUMAN	HSPA8	8	18.3	7.06	1.9e-12	821.7510	3	1.9	MSKGPAVGIDLGTTYSCVGVFQHGK	M(Met-loss+Acetyl)SKGPAVGIDLGTTYSCVGVFQHGK	Met-loss+Acetyl@1	25	V20130429-13_FTMSms2hcd	53.801	1	25	48.2	1.9e-12	2.2e-15	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	8	18.3	7.06	1.9e-12	991.5086	2	6.1	TVTNAVVTVPAYFNDSQR	TVTNAVVTVPAYFNDSQR		18	V20130429-13_FTMSms2hcd	46.077	138	155	38.0	2.2e-12	2.9e-15	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	8	18.3	7.06	1.9e-12	744.3547	2	0.58	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-13_FTMSms2hcd	34.696	37	49	45.8	4.4e-11	5.5e-14	6	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	8	18.3	7.06	1.9e-12	596.6688	3	0.93	IINEPTAAAIAYGLDKK	IINEPTAAAIAYGLDKK		17	V20130429-13_FTMSms2hcd	43.041	172	188	37.0	8.0e-11	2.4e-13	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	8	18.3	7.06	1.9e-12	846.3670	2	0.67	STAGDTHLGGEDFDNR	STAGDTHLGGEDFDNR		16	V20130429-13_FTMSms2hcd	22.853	221	236	40.5	2.7e-10	3.8e-13	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	8	18.3	7.06	1.9e-12	614.8172	2	-0.75	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-13_FTMSms2hcd	20.571	26	36	47.5	3.6e-10	5.4e-13	7	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	8	18.3	7.06	1.9e-12	627.3122	2	0.83	FEELNADLFR	FEELNADLFR		10	V20130429-13_FTMSms2hcd	48.345	302	311	40.5	1.5e-8	1.7e-11	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6]		P11142	HSP7C_HUMAN	HSPA8	8	18.3	7.06	1.9e-12	495.2659	2	-1.7	LSKEDIER	LSKEDIER		8	V20130429-13_FTMSms2hcd	13.353	510	517	16.8	0.026	4.4e-5	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[6-1]	0	P54652	HSP72_HUMAN	HSPA2	5	10.5	6.31	4.4e-11	744.3547	2	0.58	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-13_FTMSms2hcd	34.696	38	50	45.8	4.4e-11	5.5e-14	6	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[6-1]	0	P54652	HSP72_HUMAN	HSPA2	5	10.5	6.31	4.4e-11	596.6688	3	0.93	IINEPTAAAIAYGLDKK	IINEPTAAAIAYGLDKK		17	V20130429-13_FTMSms2hcd	43.041	173	189	37.0	8.0e-11	2.4e-13	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[6-1]	0	P54652	HSP72_HUMAN	HSPA2	5	10.5	6.31	4.4e-11	846.3670	2	0.67	STAGDTHLGGEDFDNR	STAGDTHLGGEDFDNR		16	V20130429-13_FTMSms2hcd	22.853	224	239	40.5	2.7e-10	3.8e-13	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[6-1]	0	P54652	HSP72_HUMAN	HSPA2	5	10.5	6.31	4.4e-11	614.8172	2	-0.75	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-13_FTMSms2hcd	20.571	27	37	47.5	3.6e-10	5.4e-13	7	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[6-1]	0	P54652	HSP72_HUMAN	HSPA2	5	10.5	6.31	4.4e-11	627.3122	2	0.83	FEELNADLFR	FEELNADLFR		10	V20130429-13_FTMSms2hcd	48.345	305	314	40.5	1.5e-8	1.7e-11	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[6-2]	1	P17066	HSP76_HUMAN	HSPA6	3	5.0	6.31	4.4e-11	744.3547	2	0.58	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-13_FTMSms2hcd	34.696	39	51	45.8	4.4e-11	5.5e-14	6	71028.7	HUMAN	Heat shock 70 kDa protein 6
[6-2]	1	P17066	HSP76_HUMAN	HSPA6	3	5.0	6.31	4.4e-11	614.8172	2	-0.75	VEILANDQGNR	VEILANDQGNR		11	V20130429-13_FTMSms2hcd	20.571	28	38	47.5	3.6e-10	5.4e-13	7	71028.7	HUMAN	Heat shock 70 kDa protein 6
[6-2]	1	P17066	HSP76_HUMAN	HSPA6	3	5.0	6.31	4.4e-11	495.2659	2	-1.7	LSKEEVER	LSKEEVER		8	V20130429-13_FTMSms2hcd	13.353	512	519	16.8	0.026	4.4e-5	1	71028.7	HUMAN	Heat shock 70 kDa protein 6
[6-3]	0	P08107	HSP71_HUMAN	HSPA1A	2	3.7	6.31	4.4e-11	744.3547	2	0.58	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-13_FTMSms2hcd	34.696	37	49	45.8	4.4e-11	5.5e-14	6	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[6-3]	0	P08107	HSP71_HUMAN	HSPA1A	2	3.7	6.31	4.4e-11	614.8172	2	-0.75	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-13_FTMSms2hcd	20.571	26	36	47.5	3.6e-10	5.4e-13	7	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[6-4]	0	P34931	HS71L_HUMAN	HSPA1L	2	3.7	6.31	4.4e-11	744.3547	2	0.58	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-13_FTMSms2hcd	34.696	39	51	45.8	4.4e-11	5.5e-14	6	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[6-4]	0	P34931	HS71L_HUMAN	HSPA1L	2	3.7	6.31	4.4e-11	614.8172	2	-0.75	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-13_FTMSms2hcd	20.571	28	38	47.5	3.6e-10	5.4e-13	7	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[6-5]	0	P48741	HSP77_HUMAN	HSPA7	2	6.5	6.31	4.4e-11	744.3547	2	0.58	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-13_FTMSms2hcd	34.696	39	51	45.8	4.4e-11	5.5e-14	6	40244.8	HUMAN	Putative heat shock 70 kDa protein 7
[6-5]	0	P48741	HSP77_HUMAN	HSPA7	2	6.5	6.31	4.4e-11	614.8172	2	-0.75	VEILANDQGNR	VEILANDQGNR		11	V20130429-13_FTMSms2hcd	20.571	28	38	47.5	3.6e-10	5.4e-13	7	40244.8	HUMAN	Putative heat shock 70 kDa protein 7
[6-6]	1	P11021	GRP78_HUMAN	HSPA5	2	3.5	5.82	3.6e-10	614.8172	2	-0.75	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-13_FTMSms2hcd	20.571	50	60	47.5	3.6e-10	5.4e-13	7	72333.5	HUMAN	78 kDa glucose-regulated protein
[6-6]	1	P11021	GRP78_HUMAN	HSPA5	2	3.5	5.82	3.6e-10	715.8500	2	1.2	TWNDPSVQQDIK	TWNDPSVQQDIK		12	V20130429-13_FTMSms2hcd	30.695	102	113	16.2	1.2e-5	1.3e-8	1	72333.5	HUMAN	78 kDa glucose-regulated protein
[7]		P08670	VIME_HUMAN	VIM	6	15.9	7.67	1.3e-13	635.7883	2	5.8	LGDLYEEEMR	LGDLYEEEM(Oxidation)R	Oxidation@154	10	V20130429-13_FTMSms2hcd	26.618	146	155	30.0	1.3e-13	2.2e-16	1	53652.1	HUMAN	Vimentin
[7]		P08670	VIME_HUMAN	VIM	6	15.9	7.67	1.3e-13	785.9516	2	0.49	ISLPLPNFSSLNLR	ISLPLPNFSSLNLR		14	V20130429-13_FTMSms2hcd	65.575	411	424	43.2	1.4e-10	5.0e-13	1	53652.1	HUMAN	Vimentin
[7]		P08670	VIME_HUMAN	VIM	6	15.9	7.67	1.3e-13	883.9066	2	0.66	LQDEIQNMKEEMAR	LQDEIQNM(Oxidation)KEEM(Oxidation)AR	Oxidation@372;Oxidation@376	14	V20130429-13_FTMSms2hcd	16.309	365	378	38.4	4.1e-10	4.7e-13	1	53652.1	HUMAN	Vimentin
[7]		P08670	VIME_HUMAN	VIM	6	15.9	7.67	1.3e-13	748.3970	2	0.26	TYSLGSALRPSTSR	TYSLGSALRPSTSR		14	V20130429-13_FTMSms2hcd	30.497	37	50	39.4	5.0e-10	7.7e-13	1	53652.1	HUMAN	Vimentin
[7]		P08670	VIME_HUMAN	VIM	6	15.9	7.67	1.3e-13	513.9751	3	0.18	ILLAELEQLKGQGK	ILLAELEQLKGQGK		14	V20130429-13_FTMSms2hcd	45.359	130	143	45.0	2.5e-8	2.0e-10	1	53652.1	HUMAN	Vimentin
[7]		P08670	VIME_HUMAN	VIM	6	15.9	7.67	1.3e-13	457.7325	2	-0.069	SYVTTSTR	SYVTTSTR		8	V20130429-13_FTMSms2hcd	11.273	29	36	20.2	7.8e-8	1.6e-10	1	53652.1	HUMAN	Vimentin
[8]		P62937	PPIA_HUMAN	PPIA	6	55.8	11.17	4.4e-20	779.3652	2	2.7	IIPGFMCQGGDFTR	IIPGFM(Oxidation)CQGGDFTR	Oxidation@61	14	V20130429-13_FTMSms2hcd	42.933	56	69	50.1	4.4e-20	5.4e-23	2	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[8]		P62937	PPIA_HUMAN	PPIA	6	55.8	11.17	4.4e-20	917.4407	3	1.8	HTGPGILSMANAGPNTNGSQFFICTAK	HTGPGILSM(Oxidation)ANAGPNTNGSQFFICTAK	Oxidation@100	27	V20130429-13_FTMSms2hcd	47.964	92	118	55.1	2.8e-15	2.7e-18	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[8]		P62937	PPIA_HUMAN	PPIA	6	55.8	11.17	4.4e-20	758.4025	2	1.5	TEWLDGKHVVFGK	TEWLDGKHVVFGK		13	V20130429-13_FTMSms2hcd	36.691	119	131	27.4	5.3e-7	8.5e-10	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[8]		P62937	PPIA_HUMAN	PPIA	6	55.8	11.17	4.4e-20	611.3088	3	0.32	SIYGEKFEDENFILK	SIYGEKFEDENFILK		15	V20130429-13_FTMSms2hcd	46.355	77	91	16.4	1.9e-6	2.2e-9	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[8]		P62937	PPIA_HUMAN	PPIA	6	55.8	11.17	4.4e-20	690.3836	2	2.2	VSFELFADKVPK	VSFELFADKVPK		12	V20130429-13_FTMSms2hcd	47.376	20	31	23.6	1.1e-5	2.6e-8	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[8]		P62937	PPIA_HUMAN	PPIA	6	55.8	11.17	4.4e-20	595.8090	2	1.8	KITIADCGQLE	KITIADCGQLE		11	V20130429-13_FTMSms2hcd	36.855	155	165	16.6	1.5e-4	2.3e-7	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[8-1]	0	Q9Y536	PAL4A_HUMAN	PPIAL4A	1	8.5	11.17	4.4e-20	779.3652	2	2.7	IIPGFMCQGGDFTR	IIPGFM(Oxidation)CQGGDFTR	Oxidation@61	14	V20130429-13_FTMSms2hcd	42.933	56	69	50.1	4.4e-20	5.4e-23	2	18182.0	HUMAN	Peptidyl-prolyl cis-trans isomerase A-like 4A/B/C
[9]		Q9BQE3	TBA1C_HUMAN	TUBA1C	6	18.5	6.98	2.6e-12	800.0645	3	0.15	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-13_FTMSms2hcd	48.975	85	105	34.6	2.6e-12	2.7e-15	6	49895.8	HUMAN	Tubulin alpha-1C chain
[9]		Q9BQE3	TBA1C_HUMAN	TUBA1C	6	18.5	6.98	2.6e-12	744.4434	2	0.24	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-13_FTMSms2hcd	67.443	230	243	47.0	4.3e-10	2.5e-12	5	49895.8	HUMAN	Tubulin alpha-1C chain
[9]		Q9BQE3	TBA1C_HUMAN	TUBA1C	6	18.5	6.98	2.6e-12	851.4579	2	1.6	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-13_FTMSms2hcd	57.178	65	79	46.5	4.5e-10	8.2e-13	3	49895.8	HUMAN	Tubulin alpha-1C chain
[9]		Q9BQE3	TBA1C_HUMAN	TUBA1C	6	18.5	6.98	2.6e-12	1004.4505	2	0.34	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-13_FTMSms2hcd	51.059	41	60	39.5	1.8e-9	2.0e-12	5	49895.8	HUMAN	Tubulin alpha-1C chain
[9]		Q9BQE3	TBA1C_HUMAN	TUBA1C	6	18.5	6.98	2.6e-12	805.7408	3	1.1	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-13_FTMSms2hcd	40.784	85	105	26.4	9.7e-9	1.1e-11	6	49895.8	HUMAN	Tubulin alpha-1C chain
[9]		Q9BQE3	TBA1C_HUMAN	TUBA1C	6	18.5	6.98	2.6e-12	771.3775	2	1.3	TIQFVDWCPTGFK	TIQFVDWCPTGFK		13	V20130429-13_FTMSms2hcd	59.491	340	352	24.2	3.6e-5	4.1e-8	5	49895.8	HUMAN	Tubulin alpha-1C chain
[9-1]	0	P68363	TBA1B_HUMAN	TUBA1B	5	15.5	6.98	2.6e-12	800.0645	3	0.15	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-13_FTMSms2hcd	48.975	85	105	34.6	2.6e-12	2.7e-15	6	50152.1	HUMAN	Tubulin alpha-1B chain
[9-1]	0	P68363	TBA1B_HUMAN	TUBA1B	5	15.5	6.98	2.6e-12	744.4434	2	0.24	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-13_FTMSms2hcd	67.443	230	243	47.0	4.3e-10	2.5e-12	5	50152.1	HUMAN	Tubulin alpha-1B chain
[9-1]	0	P68363	TBA1B_HUMAN	TUBA1B	5	15.5	6.98	2.6e-12	851.4579	2	1.6	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-13_FTMSms2hcd	57.178	65	79	46.5	4.5e-10	8.2e-13	3	50152.1	HUMAN	Tubulin alpha-1B chain
[9-1]	0	P68363	TBA1B_HUMAN	TUBA1B	5	15.5	6.98	2.6e-12	1004.4505	2	0.34	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-13_FTMSms2hcd	51.059	41	60	39.5	1.8e-9	2.0e-12	5	50152.1	HUMAN	Tubulin alpha-1B chain
[9-1]	0	P68363	TBA1B_HUMAN	TUBA1B	5	15.5	6.98	2.6e-12	805.7408	3	1.1	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-13_FTMSms2hcd	40.784	85	105	26.4	9.7e-9	1.1e-11	6	50152.1	HUMAN	Tubulin alpha-1B chain
[9-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	5	15.3	6.98	2.6e-12	800.0645	3	0.15	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-13_FTMSms2hcd	48.975	85	105	34.6	2.6e-12	2.7e-15	6	50136.1	HUMAN	Tubulin alpha-1A chain
[9-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	5	15.3	6.98	2.6e-12	851.4579	2	1.6	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-13_FTMSms2hcd	57.178	65	79	46.5	4.5e-10	8.2e-13	3	50136.1	HUMAN	Tubulin alpha-1A chain
[9-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	5	15.3	6.98	2.6e-12	1004.4505	2	0.34	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-13_FTMSms2hcd	51.059	41	60	39.5	1.8e-9	2.0e-12	5	50136.1	HUMAN	Tubulin alpha-1A chain
[9-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	5	15.3	6.98	2.6e-12	805.7408	3	1.1	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-13_FTMSms2hcd	40.784	85	105	26.4	9.7e-9	1.1e-11	6	50136.1	HUMAN	Tubulin alpha-1A chain
[9-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	5	15.3	6.98	2.6e-12	771.3775	2	1.3	TIQFVDWCPTGFK	TIQFVDWCPTGFK		13	V20130429-13_FTMSms2hcd	59.491	340	352	24.2	3.6e-5	4.1e-8	5	50136.1	HUMAN	Tubulin alpha-1A chain
[9-3]	0	Q9NY65	TBA8_HUMAN	TUBA8	4	10.7	6.98	2.6e-12	800.0645	3	0.15	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-13_FTMSms2hcd	48.975	85	105	34.6	2.6e-12	2.7e-15	6	50094.0	HUMAN	Tubulin alpha-8 chain
[9-3]	0	Q9NY65	TBA8_HUMAN	TUBA8	4	10.7	6.98	2.6e-12	744.4434	2	0.24	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-13_FTMSms2hcd	67.443	230	243	47.0	4.3e-10	2.5e-12	5	50094.0	HUMAN	Tubulin alpha-8 chain
[9-3]	0	Q9NY65	TBA8_HUMAN	TUBA8	4	10.7	6.98	2.6e-12	805.7408	3	1.1	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-13_FTMSms2hcd	40.784	85	105	26.4	9.7e-9	1.1e-11	6	50094.0	HUMAN	Tubulin alpha-8 chain
[9-3]	0	Q9NY65	TBA8_HUMAN	TUBA8	4	10.7	6.98	2.6e-12	771.3775	2	1.3	TIQFVDWCPTGFK	TIQFVDWCPTGFK		13	V20130429-13_FTMSms2hcd	59.491	340	352	24.2	3.6e-5	4.1e-8	5	50094.0	HUMAN	Tubulin alpha-8 chain
[9-4]	0	Q13748	TBA3C_HUMAN	TUBA3C	4	12.0	6.93	2.6e-12	800.0645	3	0.15	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-13_FTMSms2hcd	48.975	85	105	34.6	2.6e-12	2.7e-15	6	49960.0	HUMAN	Tubulin alpha-3C/D chain
[9-4]	0	Q13748	TBA3C_HUMAN	TUBA3C	4	12.0	6.93	2.6e-12	1004.4505	2	0.34	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-13_FTMSms2hcd	51.059	41	60	39.5	1.8e-9	2.0e-12	5	49960.0	HUMAN	Tubulin alpha-3C/D chain
[9-4]	0	Q13748	TBA3C_HUMAN	TUBA3C	4	12.0	6.93	2.6e-12	805.7408	3	1.1	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-13_FTMSms2hcd	40.784	85	105	26.4	9.7e-9	1.1e-11	6	49960.0	HUMAN	Tubulin alpha-3C/D chain
[9-4]	0	Q13748	TBA3C_HUMAN	TUBA3C	4	12.0	6.93	2.6e-12	771.3775	2	1.3	TIQFVDWCPTGFK	TIQFVDWCPTGFK		13	V20130429-13_FTMSms2hcd	59.491	340	352	24.2	3.6e-5	4.1e-8	5	49960.0	HUMAN	Tubulin alpha-3C/D chain
[9-5]	0	P68366	TBA4A_HUMAN	TUBA4A	3	7.8	6.98	2.6e-12	800.0645	3	0.15	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-13_FTMSms2hcd	48.975	85	105	34.6	2.6e-12	2.7e-15	6	49924.9	HUMAN	Tubulin alpha-4A chain
[9-5]	0	P68366	TBA4A_HUMAN	TUBA4A	3	7.8	6.98	2.6e-12	744.4434	2	0.24	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-13_FTMSms2hcd	67.443	230	243	47.0	4.3e-10	2.5e-12	5	49924.9	HUMAN	Tubulin alpha-4A chain
[9-5]	0	P68366	TBA4A_HUMAN	TUBA4A	3	7.8	6.98	2.6e-12	805.7408	3	1.1	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-13_FTMSms2hcd	40.784	85	105	26.4	9.7e-9	1.1e-11	6	49924.9	HUMAN	Tubulin alpha-4A chain
[9-6]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	2	7.3	5.39	1.8e-9	1004.4505	2	0.34	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-13_FTMSms2hcd	51.059	41	60	39.5	1.8e-9	2.0e-12	5	49859.0	HUMAN	Tubulin alpha-3E chain
[9-6]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	2	7.3	5.39	1.8e-9	771.3775	2	1.3	TIQFVDWCPTGFK	TIQFVDWCPTGFK		13	V20130429-13_FTMSms2hcd	59.491	340	352	24.2	3.6e-5	4.1e-8	5	49859.0	HUMAN	Tubulin alpha-3E chain
[9-7]	0	Q9H853	TBA4B_HUMAN	TUBA4B	1	5.8	5.78	4.3e-10	744.4434	2	0.24	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-13_FTMSms2hcd	67.443	169	182	47.0	4.3e-10	2.5e-12	5	27551.5	HUMAN	Putative tubulin-like protein alpha-4B
[10]		P06733	ENOA_HUMAN	ENO1	5	23.5	8.11	2.0e-14	995.8057	3	2.8	SFIKDYPVVSIEDPFDQDDWGAWQK	SFIKDYPVVSIEDPFDQDDWGAWQK		25	V20130429-13_FTMSms2hcd	65.481	282	306	44.1	2.0e-14	2.0e-17	1	47169.4	HUMAN	Alpha-enolase
[10]		P06733	ENOA_HUMAN	ENO1	5	23.5	8.11	2.0e-14	753.6500	4	2.8	HIADLAGNSEVILPVPAFNVINGGSHAGNK	HIADLAGNSEVILPVPAFNVINGGSHAGNK		30	V20130429-13_FTMSms2hcd	58.407	133	162	44.2	8.9e-12	1.8e-14	1	47169.4	HUMAN	Alpha-enolase
[10]		P06733	ENOA_HUMAN	ENO1	5	23.5	8.11	2.0e-14	766.0478	3	-3.9	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-13_FTMSms2hcd	77.736	373	394	23.8	2.6e-9	2.9e-12	3	47169.4	HUMAN	Alpha-enolase
[10]		P06733	ENOA_HUMAN	ENO1	5	23.5	8.11	2.0e-14	713.3660	2	-0.91	YISPDQLADLYK	YISPDQLADLYK		12	V20130429-13_FTMSms2hcd	48.589	270	281	36.1	7.4e-9	9.7e-12	1	47169.4	HUMAN	Alpha-enolase
[10]		P06733	ENOA_HUMAN	ENO1	5	23.5	8.11	2.0e-14	703.8612	2	-0.76	GNPTVEVDLFTSK	GNPTVEVDLFTSK		13	V20130429-13_FTMSms2hcd	44.308	16	28	13.8	3.5e-5	4.7e-8	1	47169.4	HUMAN	Alpha-enolase
[10-1]	0	P09104	ENOG_HUMAN	ENO2	1	5.1	3.74	2.6e-9	766.0478	3	-3.9	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-13_FTMSms2hcd	77.736	373	394	23.8	2.6e-9	2.9e-12	3	47269.0	HUMAN	Gamma-enolase
[10-2]	0	P13929	ENOB_HUMAN	ENO3	1	5.1	3.74	2.6e-9	766.0478	3	-3.9	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-13_FTMSms2hcd	77.736	373	394	23.8	2.6e-9	2.9e-12	3	46932.2	HUMAN	Beta-enolase
[11]		P08238	HS90B_HUMAN	HSP90AB1	5	7.9	6.96	2.8e-12	973.3990	2	-0.15	IEDVGSDEEDDSGKDKK	IEDVGS(Phospho)DEEDDSGKDKK	Phospho@255=49	17	V20130429-13_FTMSms2hcd	11.888	250	266	43.6	2.8e-12	4.5e-15	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[11]		P08238	HS90B_HUMAN	HSP90AB1	5	7.9	6.96	2.8e-12	571.2831	2	-0.62	LGIHEDSTNR	LGIHEDSTNR		10	V20130429-13_FTMSms2hcd	12.707	439	448	45.2	3.8e-10	6.2e-13	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[11]		P08238	HS90B_HUMAN	HSP90AB1	5	7.9	6.96	2.8e-12	757.3990	2	3.3	GVVDSEDLPLNISR	GVVDSEDLPLNISR		14	V20130429-13_FTMSms2hcd	44.455	379	392	26.2	3.8e-9	5.8e-12	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[11]		P08238	HS90B_HUMAN	HSP90AB1	5	7.9	6.96	2.8e-12	594.9874	3	-1.2	HLEINPDHPIVETLR	HLEINPDHPIVETLR		15	V20130429-13_FTMSms2hcd	38.228	625	639	25.7	6.4e-9	1.1e-11	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[11]		P08238	HS90B_HUMAN	HSP90AB1	5	7.9	6.96	2.8e-12	478.5166	4	-0.053	KHLEINPDHPIVETLR	KHLEINPDHPIVETLR		16	V20130429-13_FTMSms2hcd	33.454	624	639	19.4	1.4e-8	4.0e-11	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[11-1]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	1	4.5	6.96	2.8e-12	973.3990	2	-0.15	IEDVGSDEEDDSGKDKK	IEDVGS(Phospho)DEEDDSGKDKK	Phospho@177=49	17	V20130429-13_FTMSms2hcd	11.888	172	188	43.6	2.8e-12	4.5e-15	2	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[11-2]	0	P07900	HS90A_HUMAN	HSP90AA1	1	1.9	3.89	3.8e-9	757.3990	2	3.3	GVVDSEDLPLNISR	GVVDSEDLPLNISR		14	V20130429-13_FTMSms2hcd	44.455	387	400	26.2	3.8e-9	5.8e-12	3	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[11-3]	0	Q12931	TRAP1_HUMAN	TRAP1	1	2.0	3.89	3.8e-9	757.3990	2	3.3	GVVDSEDIPLNLSR	GVVDSEDIPLNLSR		14	V20130429-13_FTMSms2hcd	44.455	389	402	26.2	3.8e-9	5.8e-12	3	80110.7	HUMAN	Heat shock protein 75 kDa, mitochondrial
[12]		P62805	H4_HUMAN	HIST1H4A	4	41.7	6.38	3.3e-11	567.7747	2	-0.40	DAVTYTEHAK	DAVTYTEHAK		10	V20130429-13_FTMSms2hcd	12.096	69	78	32.2	3.3e-11	5.4e-14	1	11367.4	HUMAN	Histone H4
[12]		P62805	H4_HUMAN	HIST1H4A	4	41.7	6.38	3.3e-11	741.9023	2	-0.78	TVTAMDVVYALKR	TVTAM(Oxidation)DVVYALKR	Oxidation@85	13	V20130429-13_FTMSms2hcd	40.694	81	93	36.5	6.9e-11	1.6e-13	1	11367.4	HUMAN	Histone H4
[12]		P62805	H4_HUMAN	HIST1H4A	4	41.7	6.38	3.3e-11	527.0310	4	-0.19	VFLENVIRDAVTYTEHAK	VFLENVIRDAVTYTEHAK		18	V20130429-13_FTMSms2hcd	62.854	61	78	23.4	9.4e-9	1.4e-11	1	11367.4	HUMAN	Histone H4
[12]		P62805	H4_HUMAN	HIST1H4A	4	41.7	6.38	3.3e-11	663.3797	2	-1.1	DNIQGITKPAIR	DNIQGITKPAIR		12	V20130429-13_FTMSms2hcd	27.319	25	36	46.3	1.4e-7	5.0e-10	1	11367.4	HUMAN	Histone H4
[13]		P07355	ANXA2_HUMAN	ANXA2	3	12.4	7.45	3.4e-13	860.9257	2	1.1	GLGTDEDSLIEIICSR	GLGTDEDSLIEIICSR		16	V20130429-13_FTMSms2hcd	66.260	120	135	57.1	3.4e-13	3.6e-16	2	38604.4	HUMAN	Annexin A2
[13]		P07355	ANXA2_HUMAN	ANXA2	3	12.4	7.45	3.4e-13	825.9944	2	1.6	SALSGHLETVILGLLK	SALSGHLETVILGLLK		16	V20130429-13_FTMSms2hcd	69.714	89	104	52.1	1.1e-11	1.7e-13	2	38604.4	HUMAN	Annexin A2
[13]		P07355	ANXA2_HUMAN	ANXA2	3	12.4	7.45	3.4e-13	536.2791	2	0.58	MSTVHEILCK	M(Met-loss+Acetyl)STVHEILCK	Met-loss+Acetyl@1	10	V20130429-13_FTMSms2hcd	34.094	1	10	37.6	5.4e-11	9.9e-14	2	38604.4	HUMAN	Annexin A2
[13-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	3	12.4	7.45	3.4e-13	860.9257	2	1.1	GLGTDEDSLIEIICSR	GLGTDEDSLIEIICSR		16	V20130429-13_FTMSms2hcd	66.260	120	135	57.1	3.4e-13	3.6e-16	2	38659.3	HUMAN	Putative annexin A2-like protein
[13-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	3	12.4	7.45	3.4e-13	825.9944	2	1.6	SALSGHLETVILGLLK	SALSGHLETVILGLLK		16	V20130429-13_FTMSms2hcd	69.714	89	104	52.1	1.1e-11	1.7e-13	2	38659.3	HUMAN	Putative annexin A2-like protein
[13-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	3	12.4	7.45	3.4e-13	536.2791	2	0.58	MSTVHEILCK	M(Met-loss+Acetyl)STVHEILCK	Met-loss+Acetyl@1	10	V20130429-13_FTMSms2hcd	34.094	1	10	37.6	5.4e-11	9.9e-14	2	38659.3	HUMAN	Putative annexin A2-like protein
[14]		Q13268	DHRS2_HUMAN	DHRS2	2	10.1	8.33	8.1e-15	887.5110	3	1.9	RGAVILVSSIAAYNPVVALGVYNVSK	RGAVILVSSIAAYNPVVALGVYNVSK		26	V20130429-13_FTMSms2hcd	68.428	142	167	43.1	8.1e-15	1.2e-16	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[14]		Q13268	DHRS2_HUMAN	DHRS2	2	10.1	8.33	8.1e-15	835.4765	3	1.1	GAVILVSSIAAYNPVVALGVYNVSK	GAVILVSSIAAYNPVVALGVYNVSK		25	V20130429-13_FTMSms2hcd	74.011	143	167	35.0	3.4e-14	2.8e-16	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[15]		P09651	ROA1_HUMAN	HNRNPA1	3	14.5	8.69	3.3e-16	847.8530	2	-0.81	NQGGYGGSSSSSSYGSGR	NQGGYGGSSSSSSYGSGR		18	V20130429-13_FTMSms2hcd	11.836	353	370	32.5	3.3e-16	4.9e-19	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[15]		P09651	ROA1_HUMAN	HNRNPA1	3	14.5	8.69	3.3e-16	892.9585	2	1.8	LFIGGLSFETTDESLR	LFIGGLSFETTDESLR		16	V20130429-13_FTMSms2hcd	58.098	16	31	36.1	1.3e-9	1.7e-12	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[15]		P09651	ROA1_HUMAN	HNRNPA1	3	14.5	8.69	3.3e-16	761.0541	3	-0.95	GFAFVTFDDHDSVDKIVIQK	GFAFVTFDDHDSVDKIVIQK		20	V20130429-13_FTMSms2hcd	52.499	147	166	19.8	3.5e-4	4.5e-7	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[15-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	2	11.2	5.14	1.3e-9	892.9585	2	1.8	LFIGGLSFETTDESLR	LFIGGLSFETTDESLR		16	V20130429-13_FTMSms2hcd	58.098	16	31	36.1	1.3e-9	1.7e-12	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[15-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	2	11.2	5.14	1.3e-9	761.0541	3	-0.95	GFAFVTFDDHDSVDKIVIQK	GFAFVTFDDHDSVDKIVIQK		20	V20130429-13_FTMSms2hcd	52.499	147	166	19.8	3.5e-4	4.5e-7	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[16]		O43707	ACTN4_HUMAN	ACTN4	2	2.0	8.44	4.8e-15	1012.4855	2	2.7	AIMTYVSSFYHAFSGAQK	AIM(Oxidation)TYVSSFYHAFSGAQK	Oxidation@258	18	V20130429-13_FTMSms2hcd	53.547	256	273	39.9	4.8e-15	5.0e-18	2	104854.9	HUMAN	Alpha-actinin-4
[16]		O43707	ACTN4_HUMAN	ACTN4	2	2.0	8.44	4.8e-15	669.9925	3	-0.18	AIMTYVSSFYHAFSGAQK	AIMTYVSSFYHAFSGAQK		18	V20130429-13_FTMSms2hcd	60.928	256	273	30.9	4.3e-12	4.4e-15	2	104854.9	HUMAN	Alpha-actinin-4
[16-1]	0	P12814	ACTN1_HUMAN	ACTN1	2	2.0	8.44	4.8e-15	1012.4855	2	2.7	AIMTYVSSFYHAFSGAQK	AIM(Oxidation)TYVSSFYHAFSGAQK	Oxidation@239	18	V20130429-13_FTMSms2hcd	53.547	237	254	39.9	4.8e-15	5.0e-18	2	103058.4	HUMAN	Alpha-actinin-1
[16-1]	0	P12814	ACTN1_HUMAN	ACTN1	2	2.0	8.44	4.8e-15	669.9925	3	-0.18	AIMTYVSSFYHAFSGAQK	AIMTYVSSFYHAFSGAQK		18	V20130429-13_FTMSms2hcd	60.928	237	254	30.9	4.3e-12	4.4e-15	2	103058.4	HUMAN	Alpha-actinin-1
[17]		P19338	NUCL_HUMAN	NCL	2	6.3	7.84	6.5e-14	1251.1392	2	2.2	TLVLSNLSYSATEETLQEVFEK	TLVLSNLSYSATEETLQEVFEK		22	V20130429-13_FTMSms2hcd	70.894	487	508	44.5	6.5e-14	9.0e-17	1	76615.0	HUMAN	Nucleolin
[17]		P19338	NUCL_HUMAN	NCL	2	6.3	7.84	6.5e-14	653.3136	4	1.2	GYAFIEFASFEDAKEALNSCNKR	GYAFIEFASFEDAKEALNSCNKR		23	V20130429-13_FTMSms2hcd	59.172	524	546	36.5	1.3e-12	1.2e-15	1	76615.0	HUMAN	Nucleolin
[18]		P02765	FETUA_HUMAN	AHSG	3	3.5	5.48	2.0e-10	704.8033	2	-1.1	CDSSPDSAEDVRK	CDSSPDSAEDVRK		13	V20130429-13_FTMSms2hcd	9.637	132	144	32.6	2.0e-10	3.4e-13	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[18]		P02765	FETUA_HUMAN	AHSG	3	3.5	5.48	2.0e-10	640.7567	2	0.15	CDSSPDSAEDVR	CDSSPDSAEDVR		12	V20130429-13_FTMSms2hcd	13.176	132	143	35.2	2.2e-9	5.2e-12	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[18]		P02765	FETUA_HUMAN	AHSG	3	3.5	5.48	2.0e-10	744.7875	2	0.33	CDSSPDSAEDVRK	CDSSPDS(Phospho)AEDVRK	Phospho@134|135|138	13	V20130429-13_FTMSms2hcd	10.739	132	144	27.7	1.6e-8	4.2e-11	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[19]		P10809	CH60_HUMAN	HSPD1	2	6.3	8.30	9.0e-15	715.7155	3	1.2	ALMLQGVDLLADAVAVTMGPK	ALM(Oxidation)LQGVDLLADAVAVTM(Oxidation)GPK	Oxidation@40;Oxidation@55	21	V20130429-13_FTMSms2hcd	70.238	38	58	50.6	9.0e-15	1.6e-17	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[19]		P10809	CH60_HUMAN	HSPD1	2	6.3	8.30	9.0e-15	524.9728	3	0.58	GVMLAVDAVIAELKK	GVM(Oxidation)LAVDAVIAELKK	Oxidation@145	15	V20130429-13_FTMSms2hcd	59.276	143	157	31.1	8.9e-11	4.0e-13	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[20]		O60814	H2B1K_HUMAN	HIST1H2BK	3	27.8	7.34	5.6e-13	888.4091	2	1.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-13_FTMSms2hcd	54.725	59	73	46.7	5.6e-13	5.7e-16	14	13890.3	HUMAN	Histone H2B type 1-K
[20]		O60814	H2B1K_HUMAN	HIST1H2BK	3	27.8	7.34	5.6e-13	569.2777	2	1.6	ESYSVYVYK	ESYSVYVYK		9	V20130429-13_FTMSms2hcd	30.536	36	44	20.8	2.1e-6	3.3e-9	9	13890.3	HUMAN	Histone H2B type 1-K
[20]		O60814	H2B1K_HUMAN	HIST1H2BK	3	27.8	7.34	5.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-13_FTMSms2hcd	18.725	48	58	15.3	0.0059	8.3e-6	15	13890.3	HUMAN	Histone H2B type 1-K
[20-1]	0	P57053	H2BFS_HUMAN	H2BFS	3	27.8	7.34	5.6e-13	888.4091	2	1.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-13_FTMSms2hcd	54.725	59	73	46.7	5.6e-13	5.7e-16	14	13944.3	HUMAN	Histone H2B type F-S
[20-1]	0	P57053	H2BFS_HUMAN	H2BFS	3	27.8	7.34	5.6e-13	569.2777	2	1.6	ESYSVYVYK	ESYSVYVYK		9	V20130429-13_FTMSms2hcd	30.536	36	44	20.8	2.1e-6	3.3e-9	9	13944.3	HUMAN	Histone H2B type F-S
[20-1]	0	P57053	H2BFS_HUMAN	H2BFS	3	27.8	7.34	5.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-13_FTMSms2hcd	18.725	48	58	15.3	0.0059	8.3e-6	15	13944.3	HUMAN	Histone H2B type F-S
[20-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	3	27.8	7.34	5.6e-13	888.4091	2	1.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-13_FTMSms2hcd	54.725	59	73	46.7	5.6e-13	5.7e-16	14	13936.3	HUMAN	Histone H2B type 1-D
[20-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	3	27.8	7.34	5.6e-13	569.2777	2	1.6	ESYSVYVYK	ESYSVYVYK		9	V20130429-13_FTMSms2hcd	30.536	36	44	20.8	2.1e-6	3.3e-9	9	13936.3	HUMAN	Histone H2B type 1-D
[20-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	3	27.8	7.34	5.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-13_FTMSms2hcd	18.725	48	58	15.3	0.0059	8.3e-6	15	13936.3	HUMAN	Histone H2B type 1-D
[20-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	3	27.8	7.34	5.6e-13	888.4091	2	1.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-13_FTMSms2hcd	54.725	59	73	46.7	5.6e-13	5.7e-16	14	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[20-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	3	27.8	7.34	5.6e-13	569.2777	2	1.6	ESYSVYVYK	ESYSVYVYK		9	V20130429-13_FTMSms2hcd	30.536	36	44	20.8	2.1e-6	3.3e-9	9	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[20-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	3	27.8	7.34	5.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-13_FTMSms2hcd	18.725	48	58	15.3	0.0059	8.3e-6	15	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[20-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	3	27.8	7.34	5.6e-13	888.4091	2	1.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-13_FTMSms2hcd	54.725	59	73	46.7	5.6e-13	5.7e-16	14	13920.3	HUMAN	Histone H2B type 2-F
[20-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	3	27.8	7.34	5.6e-13	569.2777	2	1.6	ESYSVYVYK	ESYSVYVYK		9	V20130429-13_FTMSms2hcd	30.536	36	44	20.8	2.1e-6	3.3e-9	9	13920.3	HUMAN	Histone H2B type 2-F
[20-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	3	27.8	7.34	5.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-13_FTMSms2hcd	18.725	48	58	15.3	0.0059	8.3e-6	15	13920.3	HUMAN	Histone H2B type 2-F
[20-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	3	27.8	7.34	5.6e-13	888.4091	2	1.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-13_FTMSms2hcd	54.725	59	73	46.7	5.6e-13	5.7e-16	14	13892.2	HUMAN	Histone H2B type 1-H
[20-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	3	27.8	7.34	5.6e-13	569.2777	2	1.6	ESYSVYVYK	ESYSVYVYK		9	V20130429-13_FTMSms2hcd	30.536	36	44	20.8	2.1e-6	3.3e-9	9	13892.2	HUMAN	Histone H2B type 1-H
[20-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	3	27.8	7.34	5.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-13_FTMSms2hcd	18.725	48	58	15.3	0.0059	8.3e-6	15	13892.2	HUMAN	Histone H2B type 1-H
[20-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	3	27.8	7.34	5.6e-13	888.4091	2	1.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-13_FTMSms2hcd	54.725	59	73	46.7	5.6e-13	5.7e-16	14	13922.3	HUMAN	Histone H2B type 1-N
[20-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	3	27.8	7.34	5.6e-13	569.2777	2	1.6	ESYSVYVYK	ESYSVYVYK		9	V20130429-13_FTMSms2hcd	30.536	36	44	20.8	2.1e-6	3.3e-9	9	13922.3	HUMAN	Histone H2B type 1-N
[20-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	3	27.8	7.34	5.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-13_FTMSms2hcd	18.725	48	58	15.3	0.0059	8.3e-6	15	13922.3	HUMAN	Histone H2B type 1-N
[20-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	3	27.8	7.34	5.6e-13	888.4091	2	1.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-13_FTMSms2hcd	54.725	59	73	46.7	5.6e-13	5.7e-16	14	13989.4	HUMAN	Histone H2B type 1-M
[20-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	3	27.8	7.34	5.6e-13	569.2777	2	1.6	ESYSVYVYK	ESYSVYVYK		9	V20130429-13_FTMSms2hcd	30.536	36	44	20.8	2.1e-6	3.3e-9	9	13989.4	HUMAN	Histone H2B type 1-M
[20-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	3	27.8	7.34	5.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-13_FTMSms2hcd	18.725	48	58	15.3	0.0059	8.3e-6	15	13989.4	HUMAN	Histone H2B type 1-M
[20-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	3	27.8	7.34	5.6e-13	888.4091	2	1.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-13_FTMSms2hcd	54.725	59	73	46.7	5.6e-13	5.7e-16	14	13952.3	HUMAN	Histone H2B type 1-L
[20-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	3	27.8	7.34	5.6e-13	569.2777	2	1.6	ESYSVYVYK	ESYSVYVYK		9	V20130429-13_FTMSms2hcd	30.536	36	44	20.8	2.1e-6	3.3e-9	9	13952.3	HUMAN	Histone H2B type 1-L
[20-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	3	27.8	7.34	5.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-13_FTMSms2hcd	18.725	48	58	15.3	0.0059	8.3e-6	15	13952.3	HUMAN	Histone H2B type 1-L
[20-9]	0	P06899	H2B1J_HUMAN	HIST1H2BJ	2	20.6	7.34	5.6e-13	888.4091	2	1.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-13_FTMSms2hcd	54.725	59	73	46.7	5.6e-13	5.7e-16	14	13904.3	HUMAN	Histone H2B type 1-J
[20-9]	0	P06899	H2B1J_HUMAN	HIST1H2BJ	2	20.6	7.34	5.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-13_FTMSms2hcd	18.725	48	58	15.3	0.0059	8.3e-6	15	13904.3	HUMAN	Histone H2B type 1-J
[20-10]	0	P23527	H2B1O_HUMAN	HIST1H2BO	2	20.6	7.34	5.6e-13	888.4091	2	1.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-13_FTMSms2hcd	54.725	59	73	46.7	5.6e-13	5.7e-16	14	13906.3	HUMAN	Histone H2B type 1-O
[20-10]	0	P23527	H2B1O_HUMAN	HIST1H2BO	2	20.6	7.34	5.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-13_FTMSms2hcd	18.725	48	58	15.3	0.0059	8.3e-6	15	13906.3	HUMAN	Histone H2B type 1-O
[20-11]	0	P33778	H2B1B_HUMAN	HIST1H2BB	2	20.6	7.34	5.6e-13	888.4091	2	1.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-13_FTMSms2hcd	54.725	59	73	46.7	5.6e-13	5.7e-16	14	13950.3	HUMAN	Histone H2B type 1-B
[20-11]	0	P33778	H2B1B_HUMAN	HIST1H2BB	2	20.6	7.34	5.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-13_FTMSms2hcd	18.725	48	58	15.3	0.0059	8.3e-6	15	13950.3	HUMAN	Histone H2B type 1-B
[20-12]	0	Q16778	H2B2E_HUMAN	HIST2H2BE	2	20.6	7.34	5.6e-13	888.4091	2	1.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-13_FTMSms2hcd	54.725	59	73	46.7	5.6e-13	5.7e-16	14	13920.3	HUMAN	Histone H2B type 2-E
[20-12]	0	Q16778	H2B2E_HUMAN	HIST2H2BE	2	20.6	7.34	5.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-13_FTMSms2hcd	18.725	48	58	15.3	0.0059	8.3e-6	15	13920.3	HUMAN	Histone H2B type 2-E
[20-13]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	2	20.6	7.34	5.6e-13	888.4091	2	1.0	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-13_FTMSms2hcd	54.725	59	73	46.7	5.6e-13	5.7e-16	14	13908.2	HUMAN	Histone H2B type 3-B
[20-13]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	2	20.6	7.34	5.6e-13	576.2897	2	2.6	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-13_FTMSms2hcd	18.725	48	58	15.3	0.0059	8.3e-6	15	13908.2	HUMAN	Histone H2B type 3-B
[21]		P07737	PROF1_HUMAN	PFN1	2	18.6	7.31	6.1e-13	958.0388	2	2.9	TFVNITPAEVGVLVGKDR	TFVNITPAEVGVLVGKDR		18	V20130429-13_FTMSms2hcd	54.515	39	56	43.0	6.1e-13	2.7e-15	1	15054.4	HUMAN	Profilin-1
[21]		P07737	PROF1_HUMAN	PFN1	2	18.6	7.31	6.1e-13	445.7727	2	0.19	TLVLLMGK	TLVLLM(Oxidation)GK	Oxidation@114	8	V20130429-13_FTMSms2hcd	34.881	109	116	21.9	1.8e-8	8.8e-11	1	15054.4	HUMAN	Profilin-1
[22]		P09211	GSTP1_HUMAN	GSTP1	2	18.1	6.21	6.9e-11	1003.1649	3	2.8	MLLADQGQSWKEEVVTVETWQEGSLK	M(Oxidation)LLADQGQSWKEEVVTVETWQEGSLK	Oxidation@20	26	V20130429-13_FTMSms2hcd	57.495	20	45	41.8	6.9e-11	7.5e-14	1	23356.0	HUMAN	Glutathione S-transferase P
[22]		P09211	GSTP1_HUMAN	GSTP1	2	18.1	6.21	6.9e-11	669.3688	2	3.8	MPPYTVVYFPVR	M(Met-loss)PPYTVVYFPVR	Met-loss@1	12	V20130429-13_FTMSms2hcd	49.333	1	12	30.9	4.6e-10	1.0e-12	1	23356.0	HUMAN	Glutathione S-transferase P
[23]		P23528	COF1_HUMAN	CFL1	2	23.5	6.62	1.2e-11	1021.5386	3	2.6	NIILEEGKEILVGDVGQTVDDPYATFVK	NIILEEGKEILVGDVGQTVDDPYATFVK		28	V20130429-13_FTMSms2hcd	64.352	46	73	45.6	1.2e-11	2.6e-14	1	18502.7	HUMAN	Cofilin-1
[23]		P23528	COF1_HUMAN	CFL1	2	23.5	6.62	1.2e-11	669.3266	2	15	YALYDATYETK	YALYDATYETK		11	V20130429-13_FTMSms2hcd	32.318	82	92	28.8	5.4e-9	7.3e-12	2	18502.7	HUMAN	Cofilin-1
[23-1]	0	Q9Y281	COF2_HUMAN	CFL2	1	6.6	4.06	5.4e-9	669.3266	2	15	YALYDATYETK	YALYDATYETK		11	V20130429-13_FTMSms2hcd	32.318	82	92	28.8	5.4e-9	7.3e-12	2	18736.8	HUMAN	Cofilin-2
[24]		P62081	RS7_HUMAN	RPS7	2	11.9	6.36	3.6e-11	631.6010	4	0.18	TLTAVHDAILEDLVFPSEIVGKR	TLTAVHDAILEDLVFPSEIVGKR		23	V20130429-13_FTMSms2hcd	64.954	121	143	42.3	3.6e-11	1.5e-13	1	22127.0	HUMAN	40S ribosomal protein S7
[24]		P62081	RS7_HUMAN	RPS7	2	11.9	6.36	3.6e-11	789.7690	3	5.0	TLTAVHDAILEDLVFPSEIVGK	TLTAVHDAILEDLVFPSEIVGK		22	V20130429-13_FTMSms2hcd	68.588	121	142	23.8	1.4e-8	4.3e-11	1	22127.0	HUMAN	40S ribosomal protein S7
[25]		P15531	NDKA_HUMAN	NME1	2	13.8	6.56	1.5e-11	672.8854	2	0.083	TFIAIKPDGVQR	TFIAIKPDGVQR		12	V20130429-13_FTMSms2hcd	32.129	7	18	44.0	1.5e-11	3.7e-14	2	17148.9	HUMAN	Nucleoside diphosphate kinase A
[25]		P15531	NDKA_HUMAN	NME1	2	13.8	6.56	1.5e-11	497.7428	2	0.85	GDFCIQVGR	GDFCIQVGR		9	V20130429-13_FTMSms2hcd	35.096	106	114	26.6	4.1e-8	7.9e-11	3	17148.9	HUMAN	Nucleoside diphosphate kinase A
[25-1]	0	P22392	NDKB_HUMAN	NME2	2	13.8	6.56	1.5e-11	672.8854	2	0.083	TFIAIKPDGVQR	TFIAIKPDGVQR		12	V20130429-13_FTMSms2hcd	32.129	7	18	44.0	1.5e-11	3.7e-14	2	17298.2	HUMAN	Nucleoside diphosphate kinase B
[25-1]	0	P22392	NDKB_HUMAN	NME2	2	13.8	6.56	1.5e-11	497.7428	2	0.85	GDFCIQVGR	GDFCIQVGR		9	V20130429-13_FTMSms2hcd	35.096	106	114	26.6	4.1e-8	7.9e-11	3	17298.2	HUMAN	Nucleoside diphosphate kinase B
[25-2]	1	O60361	NDK8_HUMAN	NME2P1	2	13.9	4.36	4.1e-8	497.7428	2	0.85	GDFCIQVGR	GDFCIQVGR		9	V20130429-13_FTMSms2hcd	35.096	91	99	26.6	4.1e-8	7.9e-11	3	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[25-2]	1	O60361	NDK8_HUMAN	NME2P1	2	13.9	4.36	4.1e-8	634.3328	2	1.1	FKPEELVDYK	FKPEELVDYK		10	V20130429-13_FTMSms2hcd	35.655	119	128	36.5	2.2e-7	3.2e-10	1	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[26]		P21333	FLNA_HUMAN	FLNA	2	2.4	5.53	6.0e-11	966.2717	4	0.50	VGSAADIPINISETDLSLLTATVVPPSGREEPCLLKR	VGSAADIPINISETDLSLLTATVVPPSGREEPCLLKR		37	V20130429-13_FTMSms2hcd	71.447	1965	2001	32.9	6.0e-11	2.5e-13	1	280741.3	HUMAN	Filamin-A
[26]		P21333	FLNA_HUMAN	FLNA	2	2.4	5.53	6.0e-11	603.9315	5	6.4	TFSVWYVPEVTGTHKVTVLFAGQHIAK	TFSVWYVPEVTGTHKVTVLFAGQHIAK		27	V20130429-13_FTMSms2hcd	56.855	341	367	27.9	6.2e-11	2.6e-13	1	280741.3	HUMAN	Filamin-A
[27]		P43487	RANG_HUMAN	RANBP1	2	16.9	5.90	9.8e-11	671.3318	4	-3.0	AWVWNTHADFADECPKPELLAIR	AWVWNTHADFADECPKPELLAIR		23	V20130429-13_FTMSms2hcd	59.758	119	141	21.9	9.8e-11	1.0e-13	1	23310.3	HUMAN	Ran-specific GTPase-activating protein
[27]		P43487	RANG_HUMAN	RANBP1	2	16.9	5.90	9.8e-11	691.3223	2	0.28	TLEEDEEELFK	TLEEDEEELFK		11	V20130429-13_FTMSms2hcd	44.135	40	50	37.8	3.7e-8	5.1e-11	1	23310.3	HUMAN	Ran-specific GTPase-activating protein
[28]		P20700	LMNB1_HUMAN	LMNB1	1	5.1	10.36	1.4e-18	1137.8644	3	2.2	TTIPEEEEEEEEAAGVVVEEELFHQQGTPR	TTIPEEEEEEEEAAGVVVEEELFHQQGTPR		30	V20130429-13_FTMSms2hcd	61.129	548	577	53.3	1.4e-18	1.4e-21	1	66408.9	HUMAN	Lamin-B1
[29]		P0C0S8	H2A1_HUMAN	HIST1H2AG	3	35.4	4.83	2.3e-9	644.3948	3	0.54	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-13_FTMSms2hcd	65.455	101	119	30.1	2.3e-9	5.9e-11	10	14091.6	HUMAN	Histone H2A type 1
[29]		P0C0S8	H2A1_HUMAN	HIST1H2AG	3	35.4	4.83	2.3e-9	526.8019	4	-0.73	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-13_FTMSms2hcd	45.677	83	100	26.4	1.5e-5	8.1e-8	7	14091.6	HUMAN	Histone H2A type 1
[29]		P0C0S8	H2A1_HUMAN	HIST1H2AG	3	35.4	4.83	2.3e-9	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-13_FTMSms2hcd	36.492	22	30	34.4	3.1e-5	5.2e-8	15	14091.6	HUMAN	Histone H2A type 1
[29-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	3	35.4	4.83	2.3e-9	644.3948	3	0.54	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-13_FTMSms2hcd	65.455	101	119	30.1	2.3e-9	5.9e-11	10	14107.6	HUMAN	Histone H2A type 1-D
[29-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	3	35.4	4.83	2.3e-9	526.8019	4	-0.73	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-13_FTMSms2hcd	45.677	83	100	26.4	1.5e-5	8.1e-8	7	14107.6	HUMAN	Histone H2A type 1-D
[29-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	3	35.4	4.83	2.3e-9	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-13_FTMSms2hcd	36.492	22	30	34.4	3.1e-5	5.2e-8	15	14107.6	HUMAN	Histone H2A type 1-D
[29-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	3	35.7	4.83	2.3e-9	644.3948	3	0.54	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-13_FTMSms2hcd	65.455	101	119	30.1	2.3e-9	5.9e-11	10	13988.5	HUMAN	Histone H2A type 2-C
[29-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	3	35.7	4.83	2.3e-9	526.8019	4	-0.73	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-13_FTMSms2hcd	45.677	83	100	26.4	1.5e-5	8.1e-8	7	13988.5	HUMAN	Histone H2A type 2-C
[29-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	3	35.7	4.83	2.3e-9	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-13_FTMSms2hcd	36.492	22	30	34.4	3.1e-5	5.2e-8	15	13988.5	HUMAN	Histone H2A type 2-C
[29-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	3	35.4	4.83	2.3e-9	644.3948	3	0.54	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-13_FTMSms2hcd	65.455	101	119	30.1	2.3e-9	5.9e-11	10	14095.6	HUMAN	Histone H2A type 2-A
[29-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	3	35.4	4.83	2.3e-9	526.8019	4	-0.73	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-13_FTMSms2hcd	45.677	83	100	26.4	1.5e-5	8.1e-8	7	14095.6	HUMAN	Histone H2A type 2-A
[29-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	3	35.4	4.83	2.3e-9	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-13_FTMSms2hcd	36.492	22	30	34.4	3.1e-5	5.2e-8	15	14095.6	HUMAN	Histone H2A type 2-A
[29-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	3	35.9	4.83	2.3e-9	644.3948	3	0.54	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-13_FTMSms2hcd	65.455	101	119	30.1	2.3e-9	5.9e-11	10	13906.4	HUMAN	Histone H2A type 1-H
[29-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	3	35.9	4.83	2.3e-9	526.8019	4	-0.73	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-13_FTMSms2hcd	45.677	83	100	26.4	1.5e-5	8.1e-8	7	13906.4	HUMAN	Histone H2A type 1-H
[29-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	3	35.9	4.83	2.3e-9	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-13_FTMSms2hcd	36.492	22	30	34.4	3.1e-5	5.2e-8	15	13906.4	HUMAN	Histone H2A type 1-H
[29-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	3	35.9	4.83	2.3e-9	644.3948	3	0.54	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-13_FTMSms2hcd	65.455	101	119	30.1	2.3e-9	5.9e-11	10	13936.4	HUMAN	Histone H2A type 1-J
[29-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	3	35.9	4.83	2.3e-9	526.8019	4	-0.73	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-13_FTMSms2hcd	45.677	83	100	26.4	1.5e-5	8.1e-8	7	13936.4	HUMAN	Histone H2A type 1-J
[29-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	3	35.9	4.83	2.3e-9	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-13_FTMSms2hcd	36.492	22	30	34.4	3.1e-5	5.2e-8	15	13936.4	HUMAN	Histone H2A type 1-J
[29-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	3	35.7	4.83	2.3e-9	644.3948	3	0.54	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-13_FTMSms2hcd	65.455	101	119	30.1	2.3e-9	5.9e-11	10	14019.5	HUMAN	Histone H2A.J
[29-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	3	35.7	4.83	2.3e-9	526.8019	4	-0.73	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-13_FTMSms2hcd	45.677	83	100	26.4	1.5e-5	8.1e-8	7	14019.5	HUMAN	Histone H2A.J
[29-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	3	35.7	4.83	2.3e-9	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-13_FTMSms2hcd	36.492	22	30	34.4	3.1e-5	5.2e-8	15	14019.5	HUMAN	Histone H2A.J
[29-7]	0	P04908	H2A1B_HUMAN	HIST1H2AB	2	21.5	4.83	2.3e-9	644.3948	3	0.54	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-13_FTMSms2hcd	65.455	101	119	30.1	2.3e-9	5.9e-11	10	14135.6	HUMAN	Histone H2A type 1-B/E
[29-7]	0	P04908	H2A1B_HUMAN	HIST1H2AB	2	21.5	4.83	2.3e-9	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-13_FTMSms2hcd	36.492	22	30	34.4	3.1e-5	5.2e-8	15	14135.6	HUMAN	Histone H2A type 1-B/E
[29-8]	0	Q7L7L0	H2A3_HUMAN	HIST3H2A	2	21.5	4.83	2.3e-9	644.3948	3	0.54	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-13_FTMSms2hcd	65.455	101	119	30.1	2.3e-9	5.9e-11	10	14121.6	HUMAN	Histone H2A type 3
[29-8]	0	Q7L7L0	H2A3_HUMAN	HIST3H2A	2	21.5	4.83	2.3e-9	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-13_FTMSms2hcd	36.492	22	30	34.4	3.1e-5	5.2e-8	15	14121.6	HUMAN	Histone H2A type 3
[29-9]	0	Q93077	H2A1C_HUMAN	HIST1H2AC	2	21.5	4.83	2.3e-9	644.3948	3	0.54	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-13_FTMSms2hcd	65.455	101	119	30.1	2.3e-9	5.9e-11	10	14105.6	HUMAN	Histone H2A type 1-C
[29-9]	0	Q93077	H2A1C_HUMAN	HIST1H2AC	2	21.5	4.83	2.3e-9	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-13_FTMSms2hcd	36.492	22	30	34.4	3.1e-5	5.2e-8	15	14105.6	HUMAN	Histone H2A type 1-C
[29-10]	0	P0C0S5	H2AZ_HUMAN	H2AFZ	1	7.0	2.59	3.1e-5	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-13_FTMSms2hcd	36.492	24	32	34.4	3.1e-5	5.2e-8	15	13552.8	HUMAN	Histone H2A.Z
[29-11]	0	P16104	H2AX_HUMAN	H2AFX	1	6.3	2.59	3.1e-5	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-13_FTMSms2hcd	36.492	22	30	34.4	3.1e-5	5.2e-8	15	15144.7	HUMAN	Histone H2A.x
[29-12]	0	Q71UI9	H2AV_HUMAN	H2AFV	1	7.0	2.59	3.1e-5	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-13_FTMSms2hcd	36.492	24	32	34.4	3.1e-5	5.2e-8	15	13508.8	HUMAN	Histone H2A.V
[29-13]	0	Q8IUE6	H2A2B_HUMAN	HIST2H2AB	1	6.9	2.59	3.1e-5	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-13_FTMSms2hcd	36.492	22	30	34.4	3.1e-5	5.2e-8	15	13995.4	HUMAN	Histone H2A type 2-B
[29-14]	0	Q96QV6	H2A1A_HUMAN	HIST1H2AA	1	6.9	2.59	3.1e-5	472.7693	2	0.10	AGLQFPVGR	AGLQFPVGR		9	V20130429-13_FTMSms2hcd	36.492	22	30	34.4	3.1e-5	5.2e-8	15	14233.6	HUMAN	Histone H2A type 1-A
[30]		P62158	CALM_HUMAN	CALM1	1	20.8	9.92	9.3e-18	1130.5494	3	1.9	MADQLTEEQIAEFKEAFSLFDKDGDGTITTK	M(Met-loss+Acetyl)ADQLTEEQIAEFKEAFSLFDKDGDGTITTK	Met-loss+Acetyl@1	31	V20130429-13_FTMSms2hcd	72.830	1	31	58.2	9.3e-18	1.0e-20	1	16837.7	HUMAN	Calmodulin
[31]		O75531	BAF_HUMAN	BANF1	2	14.6	4.51	5.4e-9	493.3098	3	0.51	AYVVLGQFLVLKK	AYVVLGQFLVLKK		13	V20130429-13_FTMSms2hcd	55.912	42	54	33.1	5.4e-9	2.2e-10	1	10058.7	HUMAN	Barrier-to-autointegration factor
[31]		O75531	BAF_HUMAN	BANF1	2	14.6	4.51	5.4e-9	675.4136	2	0.58	AYVVLGQFLVLK	AYVVLGQFLVLK		12	V20130429-13_FTMSms2hcd	64.073	42	53	33.3	6.3e-9	1.1e-10	1	10058.7	HUMAN	Barrier-to-autointegration factor
[32]		P05387	RLA2_HUMAN	RPLP2	2	24.3	4.40	1.3e-7	628.8461	2	0.34	NIEDVIAQGIGK	NIEDVIAQGIGK		12	V20130429-13_FTMSms2hcd	47.496	50	61	39.6	1.3e-7	2.5e-10	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[32]		P05387	RLA2_HUMAN	RPLP2	2	24.3	4.40	1.3e-7	591.6412	3	3.7	ILDSVGIEADDDRLNK	ILDSVGIEADDDRLNK		16	V20130429-13_FTMSms2hcd	35.135	26	41	24.7	3.1e-7	4.3e-10	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[33]		P22626	ROA2_HUMAN	HNRNPA2B1	2	10.8	6.12	4.2e-11	740.6952	3	0.17	DYFEEYGKIDTIEIITDR	DYFEEYGKIDTIEIITDR		18	V20130429-13_FTMSms2hcd	56.734	130	147	38.0	4.2e-11	4.3e-14	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[33]		P22626	ROA2_HUMAN	HNRNPA2B1	2	10.8	6.12	4.2e-11	759.7238	3	0.81	GFGFVTFDDHDPVDKIVLQK	GFGFVTFDDHDPVDKIVLQK		20	V20130429-13_FTMSms2hcd	55.495	154	173	20.9	3.8e-4	4.9e-7	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[34]		P31947	1433S_HUMAN	SFN	2	13.7	6.16	4.5e-11	945.1635	3	-0.40	LGLALNFSVFHYEIANSPEEAISLAK	LGLALNFSVFHYEIANSPEEAISLAK		26	V20130429-13_FTMSms2hcd	70.173	170	195	38.5	4.5e-11	8.3e-14	1	27774.3	HUMAN	14-3-3 protein sigma
[34]		P31947	1433S_HUMAN	SFN	2	13.7	6.16	4.5e-11	454.2664	2	0.86	NLLSVAYK	NLLSVAYK		8	V20130429-13_FTMSms2hcd	35.720	42	49	21.6	8.8e-4	3.0e-6	7	27774.3	HUMAN	14-3-3 protein sigma
[34-1]	1	P63104	1433Z_HUMAN	YWHAZ	2	6.9	2.59	2.6e-7	581.7911	2	-2.0	MDKNELVQK	Acetyl-M(Oxidation)DKNELVQK	Oxidation@1=10	9	V20130429-13_FTMSms2hcd	14.484	1	9	23.1	2.6e-7	3.7e-10	1	27745.3	HUMAN	14-3-3 protein zeta/delta
[34-1]	1	P63104	1433Z_HUMAN	YWHAZ	2	6.9	2.59	2.6e-7	454.2664	2	0.86	NLLSVAYK	NLLSVAYK		8	V20130429-13_FTMSms2hcd	35.720	42	49	21.6	8.8e-4	3.0e-6	7	27745.3	HUMAN	14-3-3 protein zeta/delta
[34-2]	0	P27348	1433T_HUMAN	YWHAQ	1	3.3	0.53	8.8e-4	454.2664	2	0.86	NLLSVAYK	NLLSVAYK		8	V20130429-13_FTMSms2hcd	35.720	42	49	21.6	8.8e-4	3.0e-6	7	27764.5	HUMAN	14-3-3 protein theta
[34-3]	0	P31946	1433B_HUMAN	YWHAB	1	3.3	0.53	8.8e-4	454.2664	2	0.86	NLLSVAYK	NLLSVAYK		8	V20130429-13_FTMSms2hcd	35.720	44	51	21.6	8.8e-4	3.0e-6	7	28082.6	HUMAN	14-3-3 protein beta/alpha
[34-4]	0	P61981	1433G_HUMAN	YWHAG	1	3.2	0.53	8.8e-4	454.2664	2	0.86	NLLSVAYK	NLLSVAYK		8	V20130429-13_FTMSms2hcd	35.720	43	50	21.6	8.8e-4	3.0e-6	7	28302.8	HUMAN	14-3-3 protein gamma
[34-5]	0	P62258	1433E_HUMAN	YWHAE	1	3.1	0.53	8.8e-4	454.2664	2	0.86	NLLSVAYK	NLLSVAYK		8	V20130429-13_FTMSms2hcd	35.720	43	50	21.6	8.8e-4	3.0e-6	7	29174.2	HUMAN	14-3-3 protein epsilon
[34-6]	0	Q04917	1433F_HUMAN	YWHAH	1	3.3	0.53	8.8e-4	454.2664	2	0.86	NLLSVAYK	NLLSVAYK		8	V20130429-13_FTMSms2hcd	35.720	43	50	21.6	8.8e-4	3.0e-6	7	28219.0	HUMAN	14-3-3 protein eta
[35]		Q96DA6	TIM14_HUMAN	DNAJC19	1	17.2	8.31	9.0e-15	887.5015	2	5.6	MASTVVAVGLTIAAAGFAGR	M(Met-loss+Acetyl)ASTVVAVGLTIAAAGFAGR	Met-loss+Acetyl@1	20	V20130429-13_FTMSms2hcd	78.108	1	20	43.4	9.0e-15	3.3e-17	1	12498.7	HUMAN	Mitochondrial import inner membrane translocase subunit TIM14
[36]		P08865	RSSA_HUMAN	RPSA	1	9.2	7.77	8.9e-14	980.4876	3	-2.9	ADHQPLTEASYVNLPTIALCNTDSPLR	ADHQPLTEASYVNLPTIALCNTDSPLR		27	V20130429-13_FTMSms2hcd	60.025	129	155	41.0	8.9e-14	1.1e-16	1	32854.4	HUMAN	40S ribosomal protein SA
[37]		Q16658	FSCN1_HUMAN	FSCN1	1	4.9	7.75	9.6e-14	873.4477	3	1.6	VGKDELFALEQSCAQVVLQAANER	VGKDELFALEQSCAQVVLQAANER		24	V20130429-13_FTMSms2hcd	73.179	248	271	50.6	9.6e-14	1.3e-16	1	54530.4	HUMAN	Fascin
[38]		P09429	HMGB1_HUMAN	HMGB1	1	5.6	7.60	1.8e-13	728.3234	2	-0.0063	MSSYAFFVQTCR	M(Oxidation)SSYAFFVQTCR	Oxidation@13	12	V20130429-13_FTMSms2hcd	44.504	13	24	42.8	1.8e-13	2.7e-16	3	24894.0	HUMAN	High mobility group protein B1
[38-1]	0	P26583	HMGB2_HUMAN	HMGB2	1	5.7	7.60	1.8e-13	728.3234	2	-0.0063	MSSYAFFVQTCR	M(Oxidation)SSYAFFVQTCR	Oxidation@13	12	V20130429-13_FTMSms2hcd	44.504	13	24	42.8	1.8e-13	2.7e-16	3	24034.0	HUMAN	High mobility group protein B2
[38-2]	0	B2RPK0	HGB1A_HUMAN	HMGB1P1	1	5.7	7.60	1.8e-13	728.3234	2	-0.0063	MSSYAFFVQTCR	M(Oxidation)SSYAFFVQTCR	Oxidation@13	12	V20130429-13_FTMSms2hcd	44.504	13	24	42.8	1.8e-13	2.7e-16	3	24238.2	HUMAN	Putative high mobility group protein B1-like 1
[39]		P35579	MYH9_HUMAN	MYH9	2	1.6	5.48	1.6e-10	539.0031	3	0.38	VISGVLQLGNIVFKK	VISGVLQLGNIVFKK		15	V20130429-13_FTMSms2hcd	57.792	342	356	34.7	1.6e-10	4.5e-12	1	226534.2	HUMAN	Myosin-9
[39]		P35579	MYH9_HUMAN	MYH9	2	1.6	5.48	1.6e-10	650.6700	3	1.4	LQQELDDLLVDLDHQR	LQQELDDLLVDLDHQR		16	V20130429-13_FTMSms2hcd	57.952	1418	1433	12.1	4.5e-4	5.9e-7	1	226534.2	HUMAN	Myosin-9
[40]		P78371	TCPB_HUMAN	CCT2	1	2.8	7.37	4.8e-13	759.4509	2	0.51	LTSFIGAIAIGDLVK	LTSFIGAIAIGDLVK		15	V20130429-13_FTMSms2hcd	67.564	26	40	40.6	4.8e-13	3.6e-15	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[41]		P10412	H14_HUMAN	HIST1H1E	1	6.8	7.06	1.8e-12	789.8971	2	-0.086	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-13_FTMSms2hcd	21.214	65	79	45.1	1.8e-12	2.4e-15	5	21865.4	HUMAN	Histone H1.4
[41-1]	0	P16402	H13_HUMAN	HIST1H1D	1	6.8	7.06	1.8e-12	789.8971	2	-0.086	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-13_FTMSms2hcd	21.214	66	80	45.1	1.8e-12	2.4e-15	5	22350.1	HUMAN	Histone H1.3
[41-2]	0	P16403	H12_HUMAN	HIST1H1C	1	7.0	7.06	1.8e-12	789.8971	2	-0.086	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-13_FTMSms2hcd	21.214	65	79	45.1	1.8e-12	2.4e-15	5	21364.9	HUMAN	Histone H1.2
[41-3]	0	P22492	H1T_HUMAN	HIST1H1T	1	7.2	7.06	1.8e-12	789.8971	2	-0.086	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-13_FTMSms2hcd	21.214	69	83	45.1	1.8e-12	2.4e-15	5	22019.2	HUMAN	Histone H1t
[41-4]	0	Q02539	H11_HUMAN	HIST1H1A	1	7.0	7.06	1.8e-12	789.8971	2	-0.086	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-13_FTMSms2hcd	21.214	68	82	45.1	1.8e-12	2.4e-15	5	21842.3	HUMAN	Histone H1.1
[42]		Q15365	PCBP1_HUMAN	PCBP1	1	5.9	6.88	2.6e-12	1089.0984	2	-1.3	QVTITGSAASISLAQYLINAR	QVTITGSAASISLAQYLINAR		21	V20130429-13_FTMSms2hcd	63.914	326	346	39.1	2.6e-12	7.8e-15	1	37498.2	HUMAN	Poly(rC)-binding protein 1
[43]		P42025	ACTY_HUMAN	ACTR1B	1	5.1	6.86	5.4e-13	700.7191	3	2.5	LYSTWIGGSILASLDTFKK	LYSTWIGGSILASLDTFKK		19	V20130429-13_FTMSms2hcd	70.320	337	355	35.2	5.4e-13	1.4e-15	2	42293.8	HUMAN	Beta-centractin
[43-1]	0	P61163	ACTZ_HUMAN	ACTR1A	1	5.1	6.86	5.4e-13	700.7191	3	2.5	LYSTWIGGSILASLDTFKK	LYSTWIGGSILASLDTFKK		19	V20130429-13_FTMSms2hcd	70.320	337	355	35.2	5.4e-13	1.4e-15	2	42614.1	HUMAN	Alpha-centractin
[44]		Q15843	NEDD8_HUMAN	NEDD8	1	17.3	6.82	5.1e-12	730.9699	2	0.94	ILGGSVLHLVLALR	ILGGSVLHLVLALR		14	V20130429-13_FTMSms2hcd	67.482	61	74	46.4	5.1e-12	4.6e-13	1	9071.6	HUMAN	NEDD8
[45]		P00558	PGK1_HUMAN	PGK1	1	7.2	6.68	7.7e-12	843.6912	4	0.53	VADKIQLINNMLDKVNEMIIGGGMAFTFLK	VADKIQLINNM(Oxidation)LDKVNEM(Oxidation)IIGGGM(Oxidation)AFTFLK	Oxidation@227;Oxidation@234;Oxidation@240	30	V20130429-13_FTMSms2hcd	64.007	217	246	39.6	7.7e-12	1.6e-14	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[46]		Q9Y262	EIF3L_HUMAN	EIF3L	1	3.9	6.66	1.0e-11	640.1052	4	-0.31	IWNVHSVLNVLHSLVDKSNINR	IWNVHSVLNVLHSLVDKSNINR		22	V20130429-13_FTMSms2hcd	69.161	221	242	42.1	1.0e-11	3.9e-14	1	66727.6	HUMAN	Eukaryotic translation initiation factor 3 subunit L
[47]		P06753	TPM3_HUMAN	TPM3	1	4.6	6.41	2.9e-11	738.8400	2	-5.8	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-13_FTMSms2hcd	13.229	113	125	51.9	2.9e-11	3.4e-14	4	32819.1	HUMAN	Tropomyosin alpha-3 chain
[47-1]	0	P07951	TPM2_HUMAN	TPM2	1	4.6	6.41	2.9e-11	738.8400	2	-5.8	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-13_FTMSms2hcd	13.229	113	125	51.9	2.9e-11	3.4e-14	4	32851.0	HUMAN	Tropomyosin beta chain
[47-2]	0	P09493	TPM1_HUMAN	TPM1	1	4.6	6.41	2.9e-11	738.8400	2	-5.8	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-13_FTMSms2hcd	13.229	113	125	51.9	2.9e-11	3.4e-14	4	32708.8	HUMAN	Tropomyosin alpha-1 chain
[47-3]	0	P67936	TPM4_HUMAN	TPM4	1	5.2	6.41	2.9e-11	738.8400	2	-5.8	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-13_FTMSms2hcd	13.229	77	89	51.9	2.9e-11	3.4e-14	4	28522.0	HUMAN	Tropomyosin alpha-4 chain
[48]		Q00839	HNRPU_HUMAN	HNRNPU	1	3.3	6.15	4.2e-13	1044.1793	3	9.8	GNFTLPEVAECFDEITYVELQKEEAQK	GNFTLPEVAECFDEITYVELQKEEAQK		27	V20130429-13_FTMSms2hcd	74.438	638	664	27.5	4.2e-13	4.4e-16	1	90585.2	HUMAN	Heterogeneous nuclear ribonucleoprotein U
[49]		P13804	ETFA_HUMAN	ETFA	1	7.8	6.08	2.6e-12	675.1224	4	1.2	IVAPELYIAVGISGAIQHLAGMKDSK	IVAPELYIAVGISGAIQHLAGM(Oxidation)KDSK	Oxidation@290	26	V20130429-13_FTMSms2hcd	74.628	269	294	31.1	2.6e-12	8.3e-15	1	35079.9	HUMAN	Electron transfer flavoprotein subunit alpha, mitochondrial
[50]		P50991	TCPD_HUMAN	CCT4	1	4.8	5.87	4.5e-12	855.4323	3	2.5	AQDIEAGDGTTSVVIIAGSLLDSCTK	AQDIEAGDGTTSVVIIAGSLLDSCTK		26	V20130429-13_FTMSms2hcd	73.688	97	122	30.2	4.5e-12	5.4e-15	1	57924.8	HUMAN	T-complex protein 1 subunit delta
[51]		P06732	KCRM_HUMAN	CKM	2	5.5	4.09	1.3e-8	754.4031	2	-0.88	LSVEALNSLTGEFK	LSVEALNSLTGEFK		14	V20130429-13_FTMSms2hcd	55.246	157	170	31.0	1.3e-8	1.9e-11	1	43101.5	HUMAN	Creatine kinase M-type
[51]		P06732	KCRM_HUMAN	CKM	2	5.5	4.09	1.3e-8	454.2480	2	0.40	FEEILTR	FEEILTR		7	V20130429-13_FTMSms2hcd	30.172	308	314	28.9	2.6e-4	5.1e-7	1	43101.5	HUMAN	Creatine kinase M-type
[52]		P61978	HNRPK_HUMAN	HNRNPK	1	3.7	5.76	1.8e-10	615.0312	3	0.21	ILSISADIETIGEILKK	ILSISADIETIGEILKK		17	V20130429-13_FTMSms2hcd	71.140	87	103	37.8	1.8e-10	2.1e-12	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[53]		O95067	CCNB2_HUMAN	CCNB2	1	5.8	5.58	1.0e-9	836.4248	3	3.9	MALLRRPTVSSDLENIDTGVNSK	M(Met-loss+Acetyl)ALLRRPT(Phospho)VSSDLENIDTGVNSK	Met-loss+Acetyl@1;Phospho@8=6	23	V20130429-13_FTMSms2hcd	49.640	1	23	43.6	1.0e-9	1.3e-12	1	45282.0	HUMAN	G2/mitotic-specific cyclin-B2
[54]		P61604	CH10_HUMAN	HSPE1	2	20.6	3.89	6.3e-8	658.3838	2	1.8	VLQATVVAVGSGSK	VLQATVVAVGSGSK		14	V20130429-13_FTMSms2hcd	30.104	41	54	32.8	6.3e-8	2.0e-10	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[54]		P61604	CH10_HUMAN	HSPE1	2	20.6	3.89	6.3e-8	454.2558	2	0.78	FLPLFDR	FLPLFDR		7	V20130429-13_FTMSms2hcd	49.070	9	15	27.6	7.8e-4	1.8e-6	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[55]		P37802	TAGL2_HUMAN	TAGLN2	2	12.6	4.00	6.7e-8	640.2986	2	-1.1	NFSDNQLQEGK	NFSDNQLQEGK		11	V20130429-13_FTMSms2hcd	20.648	161	171	34.1	6.7e-8	1.1e-10	1	22391.7	HUMAN	Transgelin-2
[55]		P37802	TAGL2_HUMAN	TAGLN2	2	12.6	4.00	6.7e-8	708.3041	2	-2.3	GASQAGMTGYGMPR	GASQAGM(Oxidation)TGYGM(Oxidation)PR	Oxidation@189;Oxidation@194	14	V20130429-13_FTMSms2hcd	11.927	183	196	15.9	0.0023	4.0e-6	2	22391.7	HUMAN	Transgelin-2
[56]		P08754	GNAI3_HUMAN	GNAI3	1	4.5	5.44	1.6e-12	895.0355	2	3.1	VVVYSNTIQSIIAIIR	VVVYSNTIQSIIAIIR		16	V20130429-13_FTMSms2hcd	73.123	71	86	23.5	1.6e-12	2.5e-14	1	40532.6	HUMAN	Guanine nucleotide-binding protein G(k) subunit alpha
[57]		P62847	RS24_HUMAN	RPS24	1	9.0	5.41	1.6e-11	699.8751	2	0.94	TTPDVIFVFGFR	TTPDVIFVFGFR		12	V20130429-13_FTMSms2hcd	65.588	50	61	28.7	1.6e-11	2.9e-14	1	15423.3	HUMAN	40S ribosomal protein S24
[58]		Q15366	PCBP2_HUMAN	PCBP2	1	5.8	5.40	5.1e-11	735.7467	3	0.81	QVTITGSAASISLAQYLINVR	QVTITGSAASISLAQYLINVR		21	V20130429-13_FTMSms2hcd	66.326	334	354	31.2	5.1e-11	2.0e-13	1	38580.4	HUMAN	Poly(rC)-binding protein 2
[59]		P52272	HNRPM_HUMAN	HNRNPM	1	4.5	5.27	5.4e-11	924.7192	4	-0.28	GIGTVTFEQSIEAVQAISMFNGQLLFDRPMHVK	GIGTVTFEQSIEAVQAISM(Oxidation)FNGQLLFDRPM(Oxidation)HVK	Oxidation@263;Oxidation@274	33	V20130429-13_FTMSms2hcd	76.047	245	277	30.0	5.4e-11	8.3e-14	1	77516.4	HUMAN	Heterogeneous nuclear ribonucleoprotein M
[60]		P60174	TPIS_HUMAN	TPI1	1	6.3	5.17	2.0e-9	584.3226	3	0.70	VAHALAEGLGVIACIGEK	VAHALAEGLGVIACIGEK		18	V20130429-13_FTMSms2hcd	55.048	151	168	37.5	2.0e-9	5.0e-12	1	30791.3	HUMAN	Triosephosphate isomerase
[61]		P10768	ESTD_HUMAN	ESD	1	7.4	4.98	6.5e-10	648.0648	4	-1.3	LQEGYDHSYYFIATFITDHIR	LQEGYDHSYYFIATFITDHIR		21	V20130429-13_FTMSms2hcd	67.749	254	274	33.0	6.5e-10	6.7e-13	1	31463.1	HUMAN	S-formylglutathione hydrolase
[62]		P62701	RS4X_HUMAN	RPS4X	2	8.0	3.51	7.5e-7	608.8599	2	0.24	ECLPLIIFLR	ECLPLIIFLR		10	V20130429-13_FTMSms2hcd	72.951	40	49	34.8	7.5e-7	2.5e-9	1	29598.0	HUMAN	40S ribosomal protein S4, X isoform
[62]		P62701	RS4X_HUMAN	RPS4X	2	8.0	3.51	7.5e-7	405.8916	3	0.80	GIPHLVTHDAR	GIPHLVTHDAR		11	V20130429-13_FTMSms2hcd	16.188	135	145	13.1	0.010	1.6e-5	3	29598.0	HUMAN	40S ribosomal protein S4, X isoform
[63]		P13639	EF2_HUMAN	EEF2	1	2.9	4.74	4.0e-9	901.4769	3	1.9	YVEPIEDVPCGNIVGLVGVDQFLVK	YVEPIEDVPCGNIVGLVGVDQFLVK		25	V20130429-13_FTMSms2hcd	74.971	457	481	34.9	4.0e-9	7.6e-12	1	95339.0	HUMAN	Elongation factor 2
[64]		P35232	PHB_HUMAN	PHB	2	20.6	3.04	5.9e-8	767.4115	4	0.26	GVQDIVVGEGTHFLIPWVQKPIIFDCR	GVQDIVVGEGTHFLIPWVQKPIIFDCR		27	V20130429-13_FTMSms2hcd	72.614	44	70	23.6	5.9e-8	1.5e-10	1	29804.3	HUMAN	Prohibitin
[64]		P35232	PHB_HUMAN	PHB	2	20.6	3.04	5.9e-8	781.6644	4	3.5	AATFGLILDDVSLTHLTFGKEFTEAVEAK	AATFGLILDDVSLTHLTFGKEFTEAVEAK		29	V20130429-13_FTMSms2hcd	73.205	158	186	24.1	8.2e-5	1.8e-7	1	29804.3	HUMAN	Prohibitin
[65]		P07195	LDHB_HUMAN	LDHB	1	3.3	4.34	1.3e-7	643.8695	2	0.22	LKDDEVAQLKK	LKDDEVAQLKK		11	V20130429-13_FTMSms2hcd	17.476	309	319	38.9	1.3e-7	2.9e-10	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[66]		O60716	CTND1_HUMAN	CTNND1	1	1.0	4.31	5.0e-8	553.7534	2	0.46	VGGSSVDLHR	VGGS(Phospho)SVDLHR	Phospho@268|269	10	V20130429-13_FTMSms2hcd	18.067	265	274	36.5	5.0e-8	9.1e-11	1	108170.9	HUMAN	Catenin delta-1
[67]		Q9UQ80	PA2G4_HUMAN	PA2G4	1	4.6	4.11	5.4e-10	919.3837	2	1.7	TAENATSGETLEENEAGD	TAENATSGETLEENEAGD		18	V20130429-13_FTMSms2hcd	23.004	377	394	23.9	5.4e-10	7.7e-13	1	43787.3	HUMAN	Proliferation-associated protein 2G4
[68]		P46782	RS5_HUMAN	RPS5	1	7.4	4.10	2.2e-8	787.9086	2	0.31	TIAECLADELINAAK	TIAECLADELINAAK		15	V20130429-13_FTMSms2hcd	66.071	168	182	32.5	2.2e-8	3.1e-11	1	22876.6	HUMAN	40S ribosomal protein S5
[69]		P04792	HSPB1_HUMAN	HSPB1	1	4.9	4.04	3.5e-7	582.3140	2	-0.040	LFDQAFGLPR	LFDQAFGLPR		10	V20130429-13_FTMSms2hcd	48.563	28	37	38.4	3.5e-7	5.8e-10	1	22782.7	HUMAN	Heat shock protein beta-1
[70]		O75506	HSBP1_HUMAN	HSBP1	1	39.5	3.99	3.3e-8	871.6948	4	3.3	TVQDLTSVVQTLLQQMQDKFQTMSDQIIGR	TVQDLTSVVQTLLQQM(Oxidation)QDKFQTM(Oxidation)SDQIIGR	Oxidation@23;Oxidation@30	30	V20130429-13_FTMSms2hcd	72.373	8	37	32.3	3.3e-8	4.9e-11	1	8543.7	HUMAN	Heat shock factor-binding protein 1
[71]		O00299	CLIC1_HUMAN	CLIC1	1	3.3	3.87	7.6e-9	533.3116	2	-0.57	LFMVLWLK	LFM(Oxidation)VLWLK	Oxidation@32	8	V20130429-13_FTMSms2hcd	60.238	30	37	27.7	7.6e-9	3.0e-11	1	26923.0	HUMAN	Chloride intracellular channel protein 1
[72]		P46777	RL5_HUMAN	RPL5	1	6.1	3.87	9.4e-7	624.0014	3	0.28	VGLTNYAAAYCTGLLLAR	VGLTNYAAAYCTGLLLAR		18	V20130429-13_FTMSms2hcd	67.469	90	107	39.0	9.4e-7	1.7e-9	1	34362.9	HUMAN	60S ribosomal protein L5
[73]		P11586	C1TC_HUMAN	MTHFD1	1	1.4	3.69	1.2e-8	752.8613	2	1.8	TDPTTLTDEEINR	TDPTTLTDEEINR		13	V20130429-13_FTMSms2hcd	29.983	505	517	26.9	1.2e-8	1.5e-11	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[74]		P30101	PDIA3_HUMAN	PDIA3	1	4.8	3.63	3.5e-9	859.1065	3	0.42	TFSHELSDFGLESTAGEIPVVAIR	TFSHELSDFGLESTAGEIPVVAIR		24	V20130429-13_FTMSms2hcd	60.372	306	329	23.4	3.5e-9	4.3e-12	1	56782.9	HUMAN	Protein disulfide-isomerase A3
[75]		P62826	RAN_HUMAN	RAN	1	6.5	3.62	1.8e-9	595.6423	3	0.27	SNYNFEKPFLWLAR	SNYNFEKPFLWLAR		14	V20130429-13_FTMSms2hcd	57.978	153	166	21.8	1.8e-9	2.5e-12	1	24423.3	HUMAN	GTP-binding nuclear protein Ran
[76]		Q12882	DPYD_HUMAN	DPYD	3	1.5	1.43	6.3e-4	920.4262	2	13	SLSVNEMTLSTLKEK	SLSVNEMT(Phospho)LS(Phospho)TLKEK	Phospho@267&269|267&270|269&270	15	V20130429-13_FTMSms2hcd	28.366	260	274	29.8	6.3e-4	7.0e-7	1	111402.5	HUMAN	Dihydropyrimidine dehydrogenase [NADP(+)]
[76]		Q12882	DPYD_HUMAN	DPYD	3	1.5	1.43	6.3e-4	920.4268	2	14	SLSVNEMTLSTLKEK	SLSVNEMTLS(Phospho)T(Phospho)LKEK	Phospho@267&269|267&270|269&270	15	V20130429-13_FTMSms2hcd	28.375	260	274	28.6	8.8e-4	9.7e-7	1	111402.5	HUMAN	Dihydropyrimidine dehydrogenase [NADP(+)]
[76]		Q12882	DPYD_HUMAN	DPYD	3	1.5	1.43	6.3e-4	928.4122	2	0.61	SLSVNEMTLSTLKEK	SLSVNEM(Oxidation)T(Phospho)LST(Phospho)LKEK	Oxidation@266;Phospho@260&262|260&267|260&269|260&270|262&267|262&269|262&270|267&269|267&270|269&270	15	V20130429-13_FTMSms2hcd	28.580	260	274	19.1	0.0083	9.5e-6	1	111402.5	HUMAN	Dihydropyrimidine dehydrogenase [NADP(+)]
[77]		P46778	RL21_HUMAN	RPL21	1	11.2	3.58	8.1e-9	1047.5092	2	0.54	TNGKEPELLEPIPYEFMA	TNGKEPELLEPIPYEFM(Oxidation)A	Oxidation@159	18	V20130429-13_FTMSms2hcd	57.361	143	160	24.9	8.1e-9	8.1e-12	1	18565.0	HUMAN	60S ribosomal protein L21
[78]		P49006	MRP_HUMAN	MARCKSL1	1	4.1	3.31	2.7e-7	494.2553	2	1.0	LSGLSFKR	LSGLS(Phospho)FKR	Phospho@104=22	8	V20130429-13_FTMSms2hcd	29.944	100	107	30.4	2.7e-7	4.8e-10	1	19528.9	HUMAN	MARCKS-related protein
[79]		P68431	H31_HUMAN	HIST1H3A	1	6.6	3.21	3.3e-7	516.8003	2	-1.5	YRPGTVALR	YRPGTVALR		9	V20130429-13_FTMSms2hcd	20.233	42	50	29.9	3.3e-7	8.7e-10	5	15404.2	HUMAN	Histone H3.1
[79-1]	0	P84243	H33_HUMAN	H3F3A	1	6.6	3.21	3.3e-7	516.8003	2	-1.5	YRPGTVALR	YRPGTVALR		9	V20130429-13_FTMSms2hcd	20.233	42	50	29.9	3.3e-7	8.7e-10	5	15328.0	HUMAN	Histone H3.3
[79-2]	0	Q16695	H31T_HUMAN	HIST3H3	1	6.6	3.21	3.3e-7	516.8003	2	-1.5	YRPGTVALR	YRPGTVALR		9	V20130429-13_FTMSms2hcd	20.233	42	50	29.9	3.3e-7	8.7e-10	5	15508.4	HUMAN	Histone H3.1t
[79-3]	0	Q6NXT2	H3C_HUMAN	H3F3C	1	6.7	3.21	3.3e-7	516.8003	2	-1.5	YRPGTVALR	YRPGTVALR		9	V20130429-13_FTMSms2hcd	20.233	41	49	29.9	3.3e-7	8.7e-10	5	15213.9	HUMAN	Histone H3.3C
[79-4]	0	Q71DI3	H32_HUMAN	HIST2H3A	1	6.6	3.21	3.3e-7	516.8003	2	-1.5	YRPGTVALR	YRPGTVALR		9	V20130429-13_FTMSms2hcd	20.233	42	50	29.9	3.3e-7	8.7e-10	5	15388.2	HUMAN	Histone H3.2
[80]		P14174	MIF_HUMAN	MIF	1	7.8	3.21	2.5e-5	494.2870	2	1.2	LLCGLLAER	LLCGLLAER		9	V20130429-13_FTMSms2hcd	46.635	79	87	42.3	2.5e-5	5.1e-8	1	12476.4	HUMAN	Macrophage migration inhibitory factor
[81]		P31949	S10AB_HUMAN	S100A11	1	8.6	3.14	3.1e-7	510.2541	2	0.53	ISSPTETER	ISSPTETER		9	V20130429-13_FTMSms2hcd	12.045	4	12	29.1	3.1e-7	5.1e-10	1	11740.6	HUMAN	Protein S100-A11
[82]		P25398	RS12_HUMAN	RPS12	1	17.4	2.95	1.2e-8	1137.0739	2	3.3	MAEEGIAAGGVMDVNTALQEVLK	M(Met-loss+Acetyl)AEEGIAAGGVM(Oxidation)DVNTALQEVLK	Met-loss+Acetyl@1;Oxidation@12	23	V20130429-13_FTMSms2hcd	71.782	1	23	19.6	1.2e-8	1.5e-11	1	14515.1	HUMAN	40S ribosomal protein S12
[83]		Q68DN1	CB016_HUMAN	C2orf16	1	0.6	2.86	1.4e-8	709.2838	2	13	IGATQTSTASLK	IGATQT(Phospho)S(Phospho)T(Phospho)ASLK	Phospho@1332&1333&1334|1332&1333&1336|1332&1334&1336|1333&1334&1336	12	V20130429-13_FTMSms2hcd	14.677	1327	1338	19.1	1.4e-8	3.6e-11	1	224323.2	HUMAN	Uncharacterized protein C2orf16
[84]		O60812	HNRCL_HUMAN	HNRNPCL1	1	4.1	2.63	6.7e-7	658.9009	2	0.66	VFIGNLNTLVVK	VFIGNLNTLVVK		12	V20130429-13_FTMSms2hcd	51.791	18	29	25.8	6.7e-7	5.5e-9	2	32142.6	HUMAN	Heterogeneous nuclear ribonucleoprotein C-like 1
[84-1]	0	P07910	HNRPC_HUMAN	HNRNPC	1	3.9	2.63	6.7e-7	658.9009	2	0.66	VFIGNLNTLVVK	VFIGNLNTLVVK		12	V20130429-13_FTMSms2hcd	51.791	18	29	25.8	6.7e-7	5.5e-9	2	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[85]		P00338	LDHA_HUMAN	LDHA	1	3.0	2.49	6.0e-7	567.7900	2	7.9	VTLTSEEEAR	VTLTSEEEAR		10	V20130429-13_FTMSms2hcd	18.999	306	315	24.1	6.0e-7	8.9e-10	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[86]		P13010	XRCC5_HUMAN	XRCC5	1	1.2	2.36	2.0e-6	516.3101	2	-0.62	TLFPLIEAK	TLFPLIEAK		9	V20130429-13_FTMSms2hcd	50.838	535	543	25.6	2.0e-6	8.5e-9	1	82705.3	HUMAN	X-ray repair cross-complementing protein 5
[87]		O43175	SERA_HUMAN	PHGDH	1	6.4	2.31	2.2e-7	889.2239	4	-2.8	SLTGVVNAQALTSAFSPHTKPWIGLAEALGTLMR	SLTGVVNAQALTSAFSPHTKPWIGLAEALGTLM(Oxidation)R	Oxidation@343	34	V20130429-13_FTMSms2hcd	74.822	311	344	19.9	2.2e-7	7.5e-10	1	56651.0	HUMAN	D-3-phosphoglycerate dehydrogenase
[88]		Q8N187	AL2S8_HUMAN	ALS2CR8	1	1.0	2.23	8.3e-8	464.2017	2	3.2	VETNQTR	VETNQT(Phospho)R	Phospho@536=37	7	V20130429-13_FTMSms2hcd	13.982	531	537	16.9	8.3e-8	2.1e-10	1	80698.6	HUMAN	Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein
[89]		P62316	SMD2_HUMAN	SNRPD2	1	16.9	2.15	2.1e-6	554.3301	4	8.8	MFLRGDSVIVVLRNPLIAGK	M(Oxidation)FLRGDSVIVVLRNPLIAGK	Oxidation@99	20	V20130429-13_FTMSms2hcd	56.652	99	118	23.6	2.1e-6	4.1e-8	1	13527.0	HUMAN	Small nuclear ribonucleoprotein Sm D2
[90]		P05141	ADT2_HUMAN	SLC25A5	1	6.0	2.11	1.3e-7	674.0208	3	0.93	GMGGAFVLVLYDEIKKYT	GM(Oxidation)GGAFVLVLYDEIKKYT	Oxidation@282	18	V20130429-13_FTMSms2hcd	75.092	281	298	16.7	1.3e-7	1.8e-10	1	32852.5	HUMAN	ADP/ATP translocase 2
[91]		Q9HC16	ABC3G_HUMAN	APOBEC3G	1	3.4	1.89	2.0e-5	776.8748	2	16	IYDDQGRCQEGLR	IYDDQGRCQEGLR		13	V20130429-13_FTMSms2hcd	19.581	314	326	26.4	2.0e-5	2.4e-8	1	46408.4	HUMAN	DNA dC->dU-editing enzyme APOBEC-3G
[92]		Q6ZQQ6	WDR87_HUMAN	WDR87	1	0.3	1.84	4.6e-6	610.8137	2	0.83	EEKALNLEMK	EEKALNLEM(Oxidation)K	Oxidation@1967	10	V20130429-13_FTMSms2hcd	37.508	1959	1968	22.4	4.6e-6	6.7e-9	1	333188.0	HUMAN	WD repeat-containing protein 87
[93]		P11766	ADHX_HUMAN	ADH5	1	7.5	1.82	5.4e-7	948.1800	3	1.6	GWGVSVVVGVAASGEEIATRPFQLVTGR	GWGVSVVVGVAASGEEIATRPFQLVTGR		28	V20130429-13_FTMSms2hcd	76.487	285	312	17.2	5.4e-7	1.8e-9	1	39724.6	HUMAN	Alcohol dehydrogenase class-3
[94]		O14979	HNRDL_HUMAN	HNRPDL	1	1.9	1.78	3.5e-5	457.7604	2	0.079	GFGFVLFK	GFGFVLFK		8	V20130429-13_FTMSms2hcd	57.430	190	197	26.5	3.5e-5	9.1e-8	2	46437.9	HUMAN	Heterogeneous nuclear ribonucleoprotein D-like
[94-1]	0	Q14103	HNRPD_HUMAN	HNRNPD	1	2.3	1.78	3.5e-5	457.7604	2	0.079	GFGFVLFK	GFGFVLFK		8	V20130429-13_FTMSms2hcd	57.430	139	146	26.5	3.5e-5	9.1e-8	2	38434.5	HUMAN	Heterogeneous nuclear ribonucleoprotein D0
[95]		Q86UP3	ZFHX4_HUMAN	ZFHX4	1	0.3	1.49	3.7e-6	723.3560	2	-0.14	LQIHSQYHAIR	LQIHSQY(Phospho)HAIR	Phospho@1373=12	11	V20130429-13_FTMSms2hcd	42.787	1367	1377	18.3	3.7e-6	4.5e-9	1	393733.1	HUMAN	Zinc finger homeobox protein 4
[96]		P02768	ALBU_HUMAN	ALB	1	1.1	1.34	7.9e-4	464.2497	2	-1.4	YLYEIAR	YLYEIAR		7	V20130429-13_FTMSms2hcd	31.079	162	168	29.4	7.9e-4	1.9e-6	1	69367.4	HUMAN	Serum albumin
[97]		Q9BZ72	PITM2_HUMAN	PITPNM2	1	0.5	1.27	0.0083	435.2579	2	-0.66	LEPLLER	LEPLLER		7	V20130429-13_FTMSms2hcd	30.725	769	775	34.3	0.0083	3.5e-5	1	148934.5	HUMAN	Membrane-associated phosphatidylinositol transfer protein 2
[98]		O95466	FMNL_HUMAN	FMNL1	1	0.9	1.13	1.2e-4	569.2680	2	-1.1	RDSELGPGVK	RDS(Phospho)ELGPGVK	Phospho@624	10	V20130429-13_FTMSms2hcd	16.760	622	631	22.9	1.2e-4	2.1e-7	1	121854.6	HUMAN	Formin-like protein 1
[99]		O95025	SEM3D_HUMAN	SEMA3D	1	1.5	1.08	9.4e-6	738.3130	2	2.3	IPYPRPGTCPSK	IPY(Phospho)PRPGTCPS(Phospho)K	Phospho@392=10;Phospho@397|400	12	V20130429-13_FTMSms2hcd	16.117	390	401	16.5	9.4e-6	1.5e-8	1	89652.1	HUMAN	Semaphorin-3D
[100]		Q9ULR3	PPM1H_HUMAN	PPM1H	1	3.3	0.89	5.3e-6	1008.9548	2	20	NGEIIPMSSEFTPETER	NGEIIPMSSEFT(Phospho)PETER	Phospho@307|310	17	V20130429-13_FTMSms2hcd	62.023	296	312	13.2	5.3e-6	6.2e-9	1	56448.5	HUMAN	Protein phosphatase 1H
[101]		Q9Y6I7	WSB1_HUMAN	WSB1	1	2.6	0.88	1.3e-5	646.3300	2	4.9	MASFPPRVNEK	M(Oxidation)ASFPPRVNEK	Oxidation@1	11	V20130429-13_FTMSms2hcd	54.833	1	11	15.2	1.3e-5	1.8e-8	1	47432.6	HUMAN	WD repeat and SOCS box-containing protein 1
[102]		Q4G0M1	F132B_HUMAN	FAM132B	1	4.0	0.81	1.2e-4	750.3646	2	14	AGPAARPPEPTAER	AGPAARPPEPT(Phospho)AER	Phospho@69	14	V20130429-13_FTMSms2hcd	24.663	59	72	19.8	1.2e-4	1.5e-7	1	37279.2	HUMAN	Protein FAM132B
[103]		Q7Z2K8	GRIN1_HUMAN	GPRIN1	1	1.6	0.65	5.9e-4	807.4548	2	-5.3	VGSLPLEKGSPVTTTK	VGSLPLEKGSPVTTTK		16	V20130429-13_FTMSms2hcd	74.253	606	621	21.9	5.9e-4	1.6e-6	1	102400.1	HUMAN	G protein-regulated inducer of neurite outgrowth 1
[104]		Q9NYV4	CDK12_HUMAN	CDK12	1	0.6	0.64	1.9e-4	544.7600	2	-0.81	SSSPFLSKR	SSS(Phospho)PFLSKR	Phospho@332|333|334	9	V20130429-13_FTMSms2hcd	23.308	332	340	19.1	1.9e-4	3.3e-7	1	164155.9	HUMAN	Cyclin-dependent kinase 12
[105]		Q9Y6A5	TACC3_HUMAN	TACC3	1	0.8	0.64	1.9e-4	433.2244	2	0.13	EVIEGYR	EVIEGYR		7	V20130429-13_FTMSms2hcd	19.214	734	740	19.1	1.9e-4	4.0e-7	1	90360.4	HUMAN	Transforming acidic coiled-coil-containing protein 3
[106]		Q86UQ4	ABCAD_HUMAN	ABCA13	1	0.1	0.60	0.0012	426.2715	2	0.95	HILDIIK	HILDIIK		7	V20130429-13_FTMSms2hcd	36.411	994	1000	23.1	0.0012	1.7e-5	1	576164.4	HUMAN	ATP-binding cassette sub-family A member 13
[107]		Q0D2J5	ZN763_HUMAN	ZNF763	1	2.8	0.53	1.2e-4	668.3293	2	13	ALSYKFSNTPK	ALSYKFS(Phospho)NTPK	Phospho@382|384	11	V20130429-13_FTMSms2hcd	29.905	376	386	17.0	1.2e-4	1.7e-7	1	46099.6	HUMAN	Zinc finger protein 763
[108]		P28749	RBL1_HUMAN	RBL1	1	2.0	0.51	6.1e-5	617.0600	4	14	YLREKEAVITPVASATQSVSR	YLREKEAVIT(Phospho)PVAS(Phospho)ATQSVSR	Phospho@376&389|376&391|376&393|376&395|385&389|385&391|385&393|385&395	21	V20130429-13_FTMSms2hcd	37.023	376	396	15.2	6.1e-5	6.6e-8	1	120848.1	HUMAN	Retinoblastoma-like protein 1
[109]		Q8NDV7	TNR6A_HUMAN	TNRC6A	1	1.0	0.44	1.2e-5	1136.9761	2	15	MEIDDGTSAWGDPSKYNYK	M(Oxidation)EIDDGTSAWGDPSKY(Phospho)NYK	Oxidation@999;Phospho@1014|1016	19	V20130429-13_FTMSms2hcd	43.418	999	1017	10.7	1.2e-5	1.5e-8	1	210298.9	HUMAN	Trinucleotide repeat-containing gene 6A protein
[110]		Q96MH6	TMM68_HUMAN	TMEM68	1	3.7	0.41	0.035	665.3588	2	-6.9	IPGNIMSALLER	IPGNIM(Oxidation)SALLER	Oxidation@316	12	V20130429-13_FTMSms2hcd	19.654	311	322	29.0	0.035	6.4e-5	1	37425.1	HUMAN	Transmembrane protein 68
[111]		Q9NXG0	CNTLN_HUMAN	CNTLN	1	0.7	0.40	0.0025	376.5472	3	-0.83	RQVAEANALR	RQVAEANALR		10	V20130429-13_FTMSms2hcd	15.842	776	785	22.8	0.0025	6.9e-6	1	161604.6	HUMAN	Centlein
[112]		Q6UXB4	CLC4G_HUMAN	CLEC4G	1	3.8	0.40	3.8e-5	597.3412	2	9.6	AALLDGHDLLR	AALLDGHDLLR		11	V20130429-13_FTMSms2hcd	37.292	61	71	12.9	3.8e-5	1.1e-7	1	32562.0	HUMAN	C-type lectin domain family 4 member G
[113]		Q5VVM6	CCD30_HUMAN	CCDC30	1	1.5	0.39	3.3e-4	695.3232	2	2.7	EGQKEEGSQQNR	EGQKEEGSQQNR		12	V20130429-13_FTMSms2hcd	25.199	166	177	17.9	3.3e-4	4.1e-7	1	91334.1	HUMAN	Coiled-coil domain-containing protein 30
[114]		Q8IU53	CASC2_HUMAN	CASC2	1	14.5	0.39	3.6e-4	642.4016	2	-19	KLPQGIIIVFR	KLPQGIIIVFR		11	V20130429-13_FTMSms2hcd	56.786	39	49	18.1	3.6e-4	3.0e-6	1	8607.3	HUMAN	Protein CASC2, isoforms 1/2
[115]		Q8IUG5	MY18B_HUMAN	MYO18B	1	0.3	0.34	0.0011	442.7365	2	-0.14	QMVLHEK	QMVLHEK		7	V20130429-13_FTMSms2hcd	33.947	1769	1775	20.2	0.0011	3.0e-6	1	285187.1	HUMAN	Unconventional myosin-XVIIIb
[116]		Q9H2D6	TARA_HUMAN	TRIOBP	1	0.3	0.32	0.0014	488.2714	2	-0.18	LSEEIEKK	LSEEIEKK		8	V20130429-13_FTMSms2hcd	28.567	2022	2029	20.6	0.0014	2.5e-6	1	261377.7	HUMAN	TRIO and F-actin-binding protein
[117]		P84074	HPCA_HUMAN	HPCA	1	5.2	0.27	0.031	643.8447	2	-5.0	LRPEMLQDLR	LRPEM(Oxidation)LQDLR	Oxidation@12	10	V20130429-13_FTMSms2hcd	15.404	8	17	27.4	0.031	4.8e-5	1	22427.6	HUMAN	Neuron-specific calcium-binding protein hippocalcin
[118]		O00571	DDX3X_HUMAN	DDX3X	1	2.0	0.18	0.010	735.3898	2	-3.9	IVEQDTMPPKGVR	IVEQDTMPPKGVR		13	V20130429-13_FTMSms2hcd	23.656	364	376	23.9	0.010	1.6e-5	2	73244.0	HUMAN	ATP-dependent RNA helicase DDX3X
[118-1]	0	O15523	DDX3Y_HUMAN	DDX3Y	1	2.0	0.18	0.010	735.3898	2	-3.9	IVEQDTMPPKGVR	IVEQDTMPPKGVR		13	V20130429-13_FTMSms2hcd	23.656	362	374	23.9	0.010	1.6e-5	2	73154.2	HUMAN	ATP-dependent RNA helicase DDX3Y
[119]		O14744	ANM5_HUMAN	PRMT5	1	3.3	0.18	8.2e-4	775.7702	3	-0.92	AAILPTSIFLTNKKGFPVLSK	AAILPTSIFLTNKKGFPVLS(Phospho)K	Phospho@238|247	21	V20130429-13_FTMSms2hcd	59.814	228	248	17.9	8.2e-4	4.2e-6	1	72684.5	HUMAN	Protein arginine N-methyltransferase 5
[120]		P08620	FGF4_HUMAN	FGF4	1	3.9	0.14	0.0013	412.2557	2	0.62	LPVAAQPK	LPVAAQPK		8	V20130429-13_FTMSms2hcd	34.172	58	65	18.6	0.0013	1.2e-5	1	22047.8	HUMAN	Fibroblast growth factor 4
[121]		Q9C0D5	TANC1_HUMAN	TANC1	1	0.9	0.14	0.0022	704.9975	3	-6.6	FPREGFGEDMRPFNELR	FPREGFGEDM(Oxidation)RPFNELR	Oxidation@1328	17	V20130429-13_FTMSms2hcd	55.664	1319	1335	19.9	0.0022	2.2e-6	1	202221.0	HUMAN	Protein TANC1
[122]		Q9NR33	DPOE4_HUMAN	POLE4	1	9.4	0.10	1.3e-4	636.3246	2	11	AAELFVETIAK	AAELFVET(Phospho)IAK	Phospho@77	11	V20130429-13_FTMSms2hcd	35.243	70	80	12.7	1.3e-4	2.0e-7	1	12208.9	HUMAN	DNA polymerase epsilon subunit 4
[123]		Q8NF50	DOCK8_HUMAN	DOCK8	1	0.6	0.05	5.6e-4	727.3204	2	11	LPPNYSMHSAEK	LPPNYS(Phospho)MHSAEK	Phospho@698|701	12	V20130429-13_FTMSms2hcd	15.855	693	704	15.8	5.6e-4	8.7e-7	1	238531.2	HUMAN	Dedicator of cytokinesis protein 8
[124]		Q5VY09	IER5_HUMAN	IER5	1	5.2	0.04	0.0016	874.9085	2	-8.1	EAEGTAGGWGVFPEVSR	EAEGTAGGWGVFPEVSR		17	V20130429-13_FTMSms2hcd	31.024	154	170	18.1	0.0016	1.7e-6	1	33704.0	HUMAN	Immediate early response gene 5 protein
[125]		O94772	LY6H_HUMAN	LY6H	1	9.3	0.04	2.6e-4	728.7980	2	20	QCQPSDTVCASVR	Q(Gln->pyro-Glu)CQPSDTVCAS(Phospho)VR	Gln->pyro-Glu@44;Phospho@54=10	13	V20130429-13_FTMSms2hcd	10.449	44	56	13.8	2.6e-4	5.4e-7	1	14669.2	HUMAN	Lymphocyte antigen 6H
[126]		Q03938	ZNF90_HUMAN	ZNF90	1	1.7	0.03	2.0e-4	611.3210	2	-0.32	LSSILSTHKR	LSSILST(Phospho)HKR	Phospho@329|330	10	V20130429-13_FTMSms2hcd	51.102	324	333	13.1	2.0e-4	3.0e-7	1	69058.3	HUMAN	Zinc finger protein 90
[127]		Q96PL5	ERMAP_HUMAN	ERMAP	1	8.2	0.01	8.6e-4	1004.5350	4	13	LSVHVSGHAGDAGKFHVALLGGTAELLCPLSLWPGTVPK	LSVHVSGHAGDAGKFHVALLGGT(Phospho)AELLCPLSLWPGTVPK	Phospho@45=11	39	V20130429-13_FTMSms2hcd	63.064	23	61	16.4	8.6e-4	3.4e-6	1	52605.2	HUMAN	Erythroid membrane-associated protein
[128]		Q9Y4B5	CC165_HUMAN	CCDC165	1	1.5	0.01	7.6e-4	928.4299	3	6.0	GSGVTSSPHKCLTPKAGGGATPVSSPSR	GSGVTSSPHKCLT(Phospho)PKAGGGATPVS(Phospho)SPSR	Phospho@1658=21;Phospho@1666|1669|1670|1672	28	V20130429-13_FTMSms2hcd	37.697	1646	1673	16.1	7.6e-4	7.2e-7	1	208750.8	HUMAN	Coiled-coil domain-containing protein 165
[129]		Q96GV9	CE030_HUMAN	C5orf30	1	5.3	0.01	0.0012	587.3278	2	13	QLDAGLARSSR	QLDAGLARSSR		11	V20130429-13_FTMSms2hcd	23.487	95	105	17.2	0.0012	2.1e-6	1	23083.6	HUMAN	UNC119-binding protein C5orf30
[130]		Q8N3U4	STAG2_HUMAN	STAG2	1	0.8	0.01	0.0024	617.8671	2	-8.9	HLDALLRQIR	HLDALLRQIR		10	V20130429-13_FTMSms2hcd	46.889	608	617	18.7	0.0024	1.2e-5	1	141327.7	HUMAN	Cohesin subunit SA-2
